Header Logo

WAYNE GOODMAN

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Psychiatry & Behavioral Sciences
Address1977 BUTLER BOULEVARD
vCardDownload vCard
    Other Positions
    TitleProfessor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Neurosurgery
    DivisionNeurosurgery

    TitleChair
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Psychiatry & Behavioral Sciences
    DivisionPsychiatry & Behavioral Sciences


    Collapse Research 
    Collapse research activities and funding
    UH3NS136631     (GOODMAN, WAYNE K)Sep 1, 2024 - Aug 31, 2029
    NIH
    Building Mood State Classifiers to Inform Deep Brain Stimulation (DBS) of Treatment-Resistant Bipolar Depression
    Role: Principal Investigator
    UH3NS103549     (SHETH, SAMEER ANIL)Sep 15, 2017 - Feb 28, 2026
    NIH
    Deep Brain Stimulation for Depression Using Directional Current Steering and Individualized Network Targeting
    Role: Co-Principal Investigator
    R01MH114854     (LAZARO-MUNOZ, GABRIEL)Sep 15, 2017 - Aug 31, 2021
    NIH
    Neuroethics of aDBS Systems Targeting Neuropsychiatric and Movement Disorders
    Role: Co-Principal Investigator
    UH3NS100549     (GOODMAN, WAYNE K)Sep 30, 2016 - Jun 30, 2023
    NIH
    Adaptive DBS in Non-Motor Neuropsychiatric Disorders: Regulating Limbic Circuit Imbalance
    Role: Principal Investigator
    R25MH101074     (NEW, ANTONIA S)Jul 1, 2013 - May 31, 2021
    NIH
    Combined Psychiatry Residency and PhD Training at Mount Sinai
    Role: Co-Principal Investigator
    R01MH078594     (GOODMAN, WAYNE K)Aug 18, 2006 - May 31, 2010
    NIH
    SSRI-Induced Activation Syndrome In Pediatric OCD
    Role: Principal Investigator
    R21MH064161     (WARD, HERBERT E)Aug 21, 2002 - Jun 30, 2009
    NIH
    Pilot Study of DBS for Treatment-Refractory OCD
    Role: Co-Principal Investigator
    R01MH063914     (MURPHY, TANYA K)Apr 26, 2002 - Mar 31, 2007
    NIH
    Prospective Study of 'PANDAS'
    Role: Co-Principal Investigator
    R01MH056597     (GOODMAN, WAYNE K)Mar 1, 1997 - Feb 28, 2001
    NIH
    ANTIGEN D8/17 AS A MARKER FOR CHILDHOOD ONSET OCD/TS
    Role: Principal Investigator
    R01MH045802     (GOODMAN, WAYNE K)Sep 15, 1992 - Apr 30, 2001
    NIH
    NEUROBIOLOGY AND TREATMENT OF OCD
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Hacker C, Mocchi MM, Xiao J, Metzger B, Adkinson J, Pascuzzi B, Mathura R, Oswalt D, Watrous A, Bartoli E, Allawala A, Pirtle V, Fan X, Danstrom I, Shofty B, Banks G, Zhang Y, Armenta-Salas M, Mirpour K, Mathew S, Cohn J, Borton D, Goodman W, Pouratian N, Sheth SA, Bijanki KR. Aperiodic (1/f) neural activity robustly tracks symptom severity changes in treatment-resistant depression. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024 Nov 13. PMID: 39547412.
      Citations:    
    2. Chen JC, Dhuliyawalla A, Garcia R, Robledo A, Woods JE, Alrashdan F, O'Leary S, Husain A, Price A, Crosby S, Felicella MM, Wakhloo AK, Karas P, Provenza N, Goodman W, Sheth SA, Sheth SA, Robinson JT, Kan P. Endocisternal interfaces for minimally invasive neural stimulation and recording of the brain and spinal cord. Nat Biomed Eng. 2024 Nov 11. PMID: 39528629.
      Citations:    
    3. Allam AK, Giridharan N, Hasen M, Banks GP, Reyes G, Dang H, Kabotyanski KE, Hertz AG, Heilbronner SR, Provenza N, Storch EA, Goodman WK, Sheth SA. Effective deep brain stimulation for obsessive-compulsive disorder after failed anterior capsulotomy: illustrative cases. J Neurosurg Case Lessons. 2024 Oct 28; 8(18). PMID: 39467322; PMCID: PMC11525764.
      Citations:    
    4. Dailey MM, Colombo GM, Pinciotti CM, Sadek SJ, Muscal E, Saxena K, Goodman WK, Storch EA. Parent perceptions of various treatment approaches for PANS and PANDAS. J Affect Disord. 2024 Oct 24; 369:1215-1222. PMID: 39461376.
      Citations:    Fields:    
    5. Kabotyanski KE, Yi HG, Hingorani R, Robinson BS, Cowley HP, Fifer MS, Wester BA, Lamichhane B, Sabharwal A, Allawala AB, Rajesh SV, Diab N, Mathura RK, Pirtle V, Adkinson J, Watrous AJ, Bartoli E, Xiao J, Banks GP, Mathew SJ, Goodman WK, Pitkow X, Pouratian N, Hayden BY, Provenza NR, Sheth SA. Towards objective, temporally resolved neurobehavioral predictors of emotional state. Brain Stimul. 2024 Oct 18; 17(6):1208-1212. PMID: 39427985.
      Citations:    Fields:    
    6. Reddy S, Kabotyanski KE, Hirani S, Liu T, Naqvi Z, Giridharan N, Hasen M, Provenza NR, Banks GP, Mathew SJ, Goodman WK, Sheth SA, Reddy S, Kabotyanski KE, Hirani S, Liu T, Naqvi Z, Giridharan N, Hasen M, Provenza NR, Banks GP, Mathew SJ, Goodman WK, Sheth SA. Efficacy of Deep Brain Stimulation for Treatment-Resistant Depression: Systematic Review and Meta-Analysis. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024 Aug 26. PMID: 39197490.
      Citations:    Fields:    
    7. Myers J, Xiao J, Mathura R, Shofty B, Pirtle V, Adkinson J, Allawala AB, Anand A, Gadot R, Najera R, Rey HG, Mathew SJ, Bijanki K, Banks G, Watrous A, Bartoli E, Heilbronner SR, Provenza N, Goodman WK, Pouratian N, Hayden BY, Sheth SA. Intracranial Directed Connectivity Links Subregions of the Prefrontal Cortex to Major Depression. medRxiv. 2024 Aug 08. PMID: 39148826; PMCID: PMC11326344.
      Citations:    
    8. Xiao J, Adkinson JA, Myers J, Allawala AB, Mathura RK, Pirtle V, Najera R, Provenza NR, Bartoli E, Watrous AJ, Oswalt D, Gadot R, Anand A, Shofty B, Mathew SJ, Goodman WK, Pouratian N, Pitkow X, Bijanki KR, Hayden B, Sheth SA. Beta activity in human anterior cingulate cortex mediates reward biases. Nat Commun. 2024 Jul 15; 15(1):5528. PMID: 39009561; PMCID: PMC11250824.
      Citations: 1     Fields:    Translation:Humans
    9. Provenza NR, Reddy S, Allam AK, Rajesh SV, Diab N, Reyes G, Caston RM, Katlowitz KA, Gandhi AD, Bechtold RA, Dang HQ, Najera RA, Giridharan N, Kabotyanski KE, Momin F, Hasen M, Banks GP, Mickey BJ, Kious BM, Shofty B, Hayden BY, Herron JA, Storch EA, Patel AB, Goodman WK, Sheth SA. Disruption of neural periodicity predicts clinical response after deep brain stimulation for obsessive-compulsive disorder. Nat Med. 2024 Oct; 30(10):3004-3014. PMID: 38997607; PMCID: PMC11485242.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    10. Stiede JT, Spencer SD, Onyeka O, Mangen KH, Church MJ, Goodman WK, Storch EA. Obsessive-Compulsive Disorder in Children and Adolescents. Annu Rev Clin Psychol. 2024 Jul; 20(1):355-380. PMID: 38100637.
      Citations:    Fields:    Translation:Humans
    11. Younus S, Havel L, Stiede JT, Rast CE, Saxena K, Goodman WK, Storch EA. Pediatric Treatment-Resistant Obsessive Compulsive Disorder: Treatment Options and Challenges. Paediatr Drugs. 2024 Jul; 26(4):397-409. PMID: 38877303.
      Citations:    Fields:    Translation:Humans
    12. Xiao J, Adkinson JA, Allawala AB, Banks G, Bartoli E, Fan X, Mocchi M, Pascuzzi B, Pulapaka S, Franch MC, Mathew SJ, Mathura RK, Myers J, Pirtle V, Provenza NR, Shofty B, Watrous AJ, Pitkow X, Goodman WK, Pouratian N, Sheth S, Bijanki KR, Hayden BY. Insula uses overlapping codes for emotion in self and others. bioRxiv. 2024 Jun 08. PMID: 38895233; PMCID: PMC11185604.
      Citations: 1     
    13. Chou T, Kochanowski BJ, Hayden A, Borron BM, Barbeiro MC, Xu J, Kim JW, Zhang X, Bouchard RR, Phan KL, Goodman WK, Dougherty DD. A Low-Intensity Transcranial Focused Ultrasound Parameter Exploration Study of the Ventral Capsule/Ventral Striatum. Neuromodulation. 2024 Apr 29. PMID: 38691076.
      Citations:    Fields:    
    14. Allawala AB, Bijanki KR, Adkinson J, Oswalt D, Tsolaki E, Mathew S, Mathura RK, Bartoli E, Provenza N, Watrous AJ, Xiao J, Pirtle V, Mocchi MM, Rajesh S, Diab N, Cohn JF, Borton DA, Goodman WK, Pouratian N, Sheth SA. Stereo-Electroencephalography-Guided Network Neuromodulation for Psychiatric Disorders: The Neurophysiology Monitoring Unit. Oper Neurosurg (Hagerstown). 2024 Sep 01; 27(3):329-336. PMID: 39145663; PMCID: PMC11315541.
      Citations:    Fields:    Translation:Humans
    15. Pinciotti CM, Van Kirk N, Horvath G, Storch EA, Mancebo MC, Abramowitz JS, Fontenelle LF, Goodman WK, Riemann BC, Cervin M. Co-occurring PTSD in intensive OCD treatment: Impact on treatment trajectory vs. response. J Affect Disord. 2024 May 15; 353:109-116. PMID: 38452939.
      Citations:    Fields:    Translation:Humans
    16. Allawala A, Bijanki KR, Oswalt D, Mathura RK, Adkinson J, Pirtle V, Shofty B, Robinson M, Harrison MT, Mathew SJ, Goodman WK, Pouratian N, Sheth SA, Borton DA. Prefrontal network engagement by deep brain stimulation in limbic hubs. Front Hum Neurosci. 2023; 17:1291315. PMID: 38283094; PMCID: PMC10813208.
      Citations: 2     
    17. Strouphauer E, Valenzuela-Flores C, Minhajuddin A, Slater H, Riddle DB, Pinciotti CM, Guzick AG, Hettema JM, Tonarelli S, Soutullo CA, Elmore JS, Gushanas K, Wakefield S, Goodman WK, Trivedi MH, Storch EA, Cervin M. The clinical presentation of major depressive disorder in youth with co-occurring obsessive-compulsive disorder. J Affect Disord. 2024 Mar 15; 349:349-357. PMID: 38199393.
      Citations: 1     Fields:    Translation:Humans
    18. Cervin M, McGuire JF, D'Souza JM, De Nadai AS, Aspvall K, Goodman WK, Andr?n P, Schneider SC, Geller DA, Mataix-Cols D, Storch EA. Efficacy and acceptability of cognitive-behavioral therapy and serotonin reuptake inhibitors for pediatric obsessive-compulsive disorder: a network meta-analysis. J Child Psychol Psychiatry. 2024 May; 65(5):594-609. PMID: 38171647.
      Citations: 3     Fields:    Translation:Humans
    19. Ramirez JC, Buissonni?re-Ariza V, McIngvale E, Rufino KA, Puryear LJ, Treece CA, Schneider SC, Cepeda SL, Goodman WK, Storch EA. Perceived worsening of obsessive-compulsive disorder symptoms after childbirth in women and men: An understudied phenomenon. Bull Menninger Clin. 2024; 88(1):48-60. PMID: 38527100.
      Citations:    Fields:    Translation:Humans
    20. Dembek TA, Kuhn J, Visser-Vandewalle V, Meyer GM, Hollunder B, Li N, Butenko K, Hart L, Nombela C, Mosley P, Akram H, Acevedo N, Borron BM, Chou T, Casta?o Montoya JP, Strange B, Barcia JA, Tyagi H, Castle DJ, Smith AH, Choi KS, Kopell BH, Mayberg HS, Sheth SA, Goodman W, Leentjens AFG, Richardson RM, Rossell SL, Bosanac P, Cosgrove GR, Figee M, Dougherty DD, Siddiqi SH, Zrinzo L, Joyce E, Baldermann JC, Fox MD, Neudorfer C, Horn A, Goodman WK. Deep Brain Stimulation for Obsessive-Compulsive Disorder: Optimal Stimulation Sites. Biol Psychiatry. 2024 Jul 15; 96(2):101-113. PMID: 38141909; PMCID: PMC11190041.
      Citations: 3     Fields:    Translation:Humans
    21. Sheth SA, Shofty B, Allawala A, Xiao J, Adkinson JA, Mathura RK, Pirtle V, Myers J, Oswalt D, Provenza NR, Giridharan N, Noecker AM, Banks GP, Gadot R, Najera RA, Anand A, Devara E, Dang H, Bartoli E, Watrous A, Cohn J, Borton D, Mathew SJ, McIntyre CC, Goodman W, Bijanki K, Pouratian N. Stereo-EEG-guided network modulation for psychiatric disorders: Surgical considerations. Brain Stimul. 2023 Nov-Dec; 16(6):1792-1798. PMID: 38135358; PMCID: PMC10787578.
      Citations:    Fields:    Translation:Humans
    22. Storch EA, Guzick AG, Ayton DM, Palo AD, Kook M, Candelari AE, Maye CE, McNeel M, Trent ES, Garcia JL, Onyeka OC, Rast CE, Shimshoni Y, Lebowitz ER, Goodman WK. Randomized trial comparing standard versus light intensity parent training for anxious youth. Behav Res Ther. 2024 02; 173:104451. PMID: 38154287.
      Citations: 2     Fields:    Translation:Humans
    23. Guzick AG, Cervin M, Smith EEA, Clinger J, Draper I, Goodman WK, Lijffijt M, Murphy N, Lewin AB, Schneider SC, Storch EA. Corrigendum to "Clinical characteristics, impairment, and psychiatric morbidity in 102 youth with misophonia" [J. Affect. Disord. volume 324 (2023) 395-402]. J Affect Disord. 2024 Mar 01; 348:410. PMID: 38040623.
      Citations:    Fields:    
    24. Murphy N, Lijffijt M, Guzick AG, Cervin M, Clinger J, Smith EEA, Draper I, Rast CE, Goodman WK, Schneider S, Storch EA. Alterations in attentional processing in youth with misophonia: A phenotypical cross-comparison with anxiety patients. J Affect Disord. 2024 02 15; 347:429-436. PMID: 38042307.
      Citations:    Fields:    Translation:Humans
    25. Hacker C, Mocchi MM, Xiao J, Metzger BA, Adkinson JA, Pascuzzi BR, Mathura RC, Oswalt D, Watrous A, Bartoli E, Allawala A, Pirtle V, Fan X, Danstrom I, Shofty B, Banks G, Zhang Y, Armenta-Salas M, Mirpour K, Provenza N, Mathew S, Cohn J, Borton D, Goodman W, Pouratian N, Sheth SA, Bijanki KR. Aperiodic neural activity is a biomarker for depression severity. medRxiv. 2023 Nov 08. PMID: 37986996; PMCID: PMC10659509.
      Citations:    
    26. Sm?rason O, Boedeker PJ, Guzick AG, Tendler A, Sheth SA, Goodman WK, Storch EA. Depressive symptoms during deep transcranial magnetic stimulation or sham treatment for obsessive-compulsive disorder. J Affect Disord. 2024 01 01; 344:466-472. PMID: 37852581.
      Citations:    Fields:    Translation:Humans
    27. Sm?rason O, Guzick AG, Goodman WK, Salloum A, Storch EA. Predictors and Moderators of Treatment Outcomes for Anxious Children Randomized to Computer-Assisted Cognitive Behavioral Therapy or Standard Community Care. J Child Adolesc Psychopharmacol. 2023 10; 33(8):316-324. PMID: 37861988; PMCID: PMC10616955.
      Citations:    Fields:    Translation:Humans
    28. Storch EA, Guzick AG, D'Souza J, Clinger J, Ayton D, Kook M, Rork C, Smith EE, Draper IA, Khalfe N, Rast CE, Murphy N, Lijfijjt M, Goodman WK, Cervin M. Family Accommodation in Children and Adolescents With Misophonia. Behav Ther. 2024 May; 55(3):595-604. PMID: 38670671; PMCID: PMC11055978.
      Citations: 2     Fields:    Translation:Humans
    29. Guzick AG, Schneider SC, Kook M, Rose Iacono J, Weinzimmer SA, Quast T, Olsen SM, Hughes KR, Jellinek-Russo E, Garcia AP, Candelari A, Berry LN, Goin-Kochel RP, Goodman WK, Storch EA. Parent-Led Cognitive Behavioral Teletherapy for Anxiety in Autistic Youth: A Randomized Trial Comparing Two Levels of Therapist Support. Behav Ther. 2024 May; 55(3):499-512. PMID: 38670664; PMCID: PMC11055980.
      Citations:    Fields:    Translation:Humans
    30. Fan X, Mocchi M, Pascuzzi B, Xiao J, Metzger BA, Mathura RK, Hacker C, Adkinson JA, Bartoli E, Elhassa S, Watrous AJ, Zhang Y, Goodman W, Pouratian N, Bijanki KR. Brain mechanisms underlying the emotion processing bias in treatment-resistant depression. bioRxiv. 2023 Aug 28. PMID: 37693557; PMCID: PMC10491112.
      Citations:    
    31. Fan B, Goodman W, Cho RY, Sheth SA, Bouchard RR, Aazhang B. Computational modeling and minimization of unintended neuronal excitation in a LIFU stimulation. Sci Rep. 2023 08 17; 13(1):13403. PMID: 37591991; PMCID: PMC10435497.
      Citations:    Fields:    Translation:Humans
    32. Khalfe N, Goetz AR, Trent ES, Guzick AG, Smarason O, Kook M, Olsen S, Ramirez AC, Weinzimmer SA, Berry L, Schneider SC, Goodman WK, Storch EA. Psychometric properties of the revised children's anxiety and depression scale (RCADS) for autistic youth without co-occurring intellectual disability. J Mood Anxiety Disord. 2023 Aug; 2. PMID: 37693105; PMCID: PMC10486182.
      Citations:    
    33. Moukaddam N, Lamichhane B, Salas R, Goodman W, Sabharwal A. Modeling Suicidality with Multimodal Impulsivity Characterization in Participants with Mental Health Disorder. Behav Neurol. 2023; 2023:8552180. PMID: 37575401; PMCID: PMC10423091.
      Citations:    Fields:    Translation:Humans
    34. Oluyomi AO, Schneider SC, Christian C, Alvarez JM, Sm?rason O, Goodman WK, Storch EA. Geospatial Distribution of Obsessive-Compulsive Disorder Specialists: Understanding Access as a Function of Distance, Insurance Status, and Neighborhood Socioeconomic Status. J Obsessive Compuls Relat Disord. 2023 Jul; 38. PMID: 37614722; PMCID: PMC10443932.
      Citations:    
    35. Darrow SM, Pizzagalli DA, Smoski M, Mathew SJ, Nurnberger J, Lisanby SH, Iosifescu D, Murrough JW, Yang H, Weiner RD, Sanacora G, Keefe RSE, Song A, Goodman W, Potter WZ, Krystal AD, Whitton AE. Using latent profile analyses to classify subjects with anhedonia based on reward-related measures obtained in the FAST-MAS study. J Affect Disord. 2023 10 15; 339:584-592. PMID: 37467805.
      Citations:    Fields:    Translation:Humans
    36. Swamy CP, Besheli BF, Branco LRF, Provenza NR, Sheth SA, Goodman WK, Viswanathan A, Ince NF. Pulsation artifact removal from intra-operatively recorded local field potentials using sparse signal processing and data-specific dictionary. Annu Int Conf IEEE Eng Med Biol Soc. 2023 07; 2023:1-4. PMID: 38082947; PMCID: PMC10746292.
      Citations: 1     Fields:    
    37. Merner AR, Kostick-Quenet K, Campbell TA, Pham MT, Sanchez CE, Torgerson L, Robinson J, Pereira S, Outram S, Koenig BA, Starr PA, Gunduz A, Foote KD, Okun MS, Goodman W, McGuire AL, Zuk P, L?zaro-Mu?oz G. Participant perceptions of changes in psychosocial domains following participation in an adaptive deep brain stimulation trial. Brain Stimul. 2023 Jul-Aug; 16(4):990-998. PMID: 37330169; PMCID: PMC10529988.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    38. Riddle DB, Guzick A, Minhajuddin A, Sm?rason O, Armstrong GM, Slater H, Mayes TL, Goodman LC, Baughn DL, Martin SL, Wakefield SM, Blader J, Brown R, Goodman WK, Trivedi MH, Storch EA. Obsessive-compulsive disorder in youth and young adults with depression: Clinical characteristics of comorbid presentations. J Obsessive Compuls Relat Disord. 2023 Jul; 38. PMID: 37521713; PMCID: PMC10373162.
      Citations:    
    39. Cervin M, Guzick AG, Clinger J, Smith EEA, Draper IA, Goodman WK, Lijffijt M, Murphy N, Rast CE, Schneider SC, Storch EA. Measuring misophonia in youth: A psychometric evaluation of child and parent measures. J Affect Disord. 2023 10 01; 338:180-186. PMID: 37263358; PMCID: PMC11165319.
      Citations: 3     Fields:    Translation:Humans
    40. Hitti FL, Widge AS, Riva-Posse P, Malone DA, Okun MS, Shanechi MM, Foote KD, Lisanby SH, Ankudowich E, Chivukula S, Chang EF, Gunduz A, Hamani C, Feinsinger A, Kubu CS, Chiong W, Chandler JA, Carbunaru R, Cheeran B, Raike RS, Davis RA, Halpern CH, Vanegas-Arroyave N, Markovic D, Bick SK, McIntyre CC, Richardson RM, Dougherty DD, Kopell BH, Sweet JA, Goodman WK, Sheth SA, Pouratian N. Future directions in psychiatric neurosurgery: Proceedings of the 2022 American Society for Stereotactic and Functional Neurosurgery meeting on surgical neuromodulation for psychiatric disorders. Brain Stimul. 2023 May-Jun; 16(3):867-878. PMID: 37217075; PMCID: PMC11189296.
      Citations: 3     Fields:    Translation:Humans
    41. Mattson SA, D'Souza J, Wojcik KD, Guzick AG, Goodman WK, Storch EA. A systematic review of treatments for misophonia. Pers Med Psychiatry. 2023 Jul-Aug; 39-40. PMID: 37333720; PMCID: PMC10276561.
      Citations: 2     
    42. Gault JM, Hosokawa P, Kramer D, Saks ER, Appelbaum PS, Thompson JA, Olincy A, Cascella N, Sawa A, Goodman W, Moukaddam N, Sheth SA, Anderson WS, Davis RA. Postsurgical morbidity and mortality favorably informs deep brain stimulation for new indications including schizophrenia and schizoaffective disorder. Front Surg. 2023; 10:958452. PMID: 37066004; PMCID: PMC10098000.
      Citations:    
    43. Dang HQ, Provenza NR, Banks GP, Giridharan N, Avendano-Ortega M, McKay SA, Devara E, Shofty B, Storch EA, Sheth SA, Goodman WK. Attenuating side effects of deep brain stimulation in the bed nucleus of the stria terminalis for obsessive compulsive disorder using current-steering strategies. Brain Stimul. 2023 Mar-Apr; 16(2):650-652. PMID: 36958600.
      Citations:    Fields:    Translation:Humans
    44. Leuchter JD, Kook M, Geller DA, Hertz AG, Garcia J, Trent ES, Dibbs T, Onyeka O, Goodman WK, Guzick AG, Wiese AD, Palo AD, Small BJ, Simpson HB, Havel LK, Nibras SA, Saxena K, Storch EA. Promoting OCD WEllness and resilience (POWER) study: Rationale, design, and methods. Psychiatry Res Commun. 2023 Jun; 3(2). PMID: 37377947; PMCID: PMC10299759.
      Citations:    
    45. Najera RA, Provenza N, Dang H, Katlowitz KA, Hertz A, Reddy S, Shofty B, Bellows ST, Storch EA, Goodman WK, Sheth SA. Dual-Target Deep Brain Stimulation for Obsessive-Compulsive Disorder and Tourette Syndrome. Biol Psychiatry. 2023 06 01; 93(11):e53-e55. PMID: 36863881; PMCID: PMC11166381.
      Citations:    Fields:    Translation:Humans
    46. Fuselier MN, Guzick AG, Bakhshaie J, Wood JJ, Kendall PC, Kerns CM, Small BJ, Goodman WK, Storch EA. Examining the Relationship Between Anxiety Severity and Autism-Related Challenges During Cognitive Behavioral Therapy for Children with Autism. J Autism Dev Disord. 2024 May; 54(5):1849-1856. PMID: 36847894.
      Citations:    Fields:    
    47. Crowley JJ, Cappi C, Ochoa-Panaifo ME, Frederick RM, Kook M, Wiese AD, Rancourt D, Atkinson EG, Giusti-Rodriguez P, Anderberg JL, Latin American Trans-ancestry INitiative for OCD genomics (LATINO), Brazilian Obsessive-Compulsive S, Abramowitz JS, Adorno VR, Aguirre C, Alves GS, Alves GS, Ancalade N, Espinosa AAA, Arnold PD, Ayton DM, Barbosa IG, Castano LMB, Barrera CN, Prieto MB, Berardo MC, Berrones D, Best JR, Bigdeli TB, Burton CL, Callahan JL, Carneiro MCB, Cepeda SL, Chazelle E, Chire JM, Munoz MC, Quiroz PC, Cobite J, Comer JS, Costa DL, Crosbie J, Cruz VO, Dager G, Daza LF, de la Rosa-G?mez A, Del R?o D, Delage FZ, Dreher CB, Fay L, Fazio T, Ferr?o YA, Ferreira GM, Figueroa EG, Fontenelle LF, Forero DA, Fragoso DT, Gadad BS, Garrison SR, Gonz?lez A, Gonzalez LD, Gonz?lez MA, Gonzalez-Barrios P, Goodman W, Guintivano J, Guttfreund DG, Guzick AG, Halvorsen MW, Hovey JD, Janssen-Aguilar R, Jensen M, Reynolds AZJ, Lujambio JAJ, Khalfe N, Knutsen MA, Lack C, Lanzagorta N, Lima MO, Longhurst MO, Martinez DAL, Luna ES, Marques AH, Martinez M, de Los Angeles Matos M, Maye CE, McGuire JF, Menezes G, Minaya C, Mi?o T, Mithani SM, de Oca CM, Morales-Rivero A, Moreira-de-Oliveira ME, Morris OJ, Mu?oz SI, Naqqash Z, Bracho AAN, Bracho BEN, Rojas MCO, Castaman LAO, Ortega I, Patel DI, Patrick AK, Mino MPY, Orellana JLP, Stumpf BP, Peregrina T, Duarte TP, Piacsek KL, Placencia M, Quarantini LC, Quarantini-Alvim Y, Ramos RT, Ramos IC, Ramos VR, Ramsey KA, Ray EV, Richter MA, Riemann BC, Rivas JC, Rosario MC, Ruggero CJ, Ruiz-Chow AA, Ruiz-Velasco A, Sampaio AS, Saraiva LC, Schachar RJ, Schneider SC, Schweissing EJ, Seligman LD, Shavitt RG, Soileau KJ, Stewart SE, Storch SB, Strouphauer ER, Timpano KR, Trevi?o-de la Garza B, Vargas-Medrano J, V?squez MI, Martinez GV, Weinzimmer SA, Yanez MA, Zai G, Zapata-Restrepo LM, Zappa LM, Zepeda-Burgos RM, Zoghbi AW, Miguel EC, Rodriguez CI, Mallen MCM, Moya PR, Borda T, Moyano MB, Mattheisen M, Pereira S, L?zaro-Mu?oz G, Martinez-Gonzalez KG, Pato MT, Nicolini H, Storch EA. Latin American Trans-ancestry INitiative for OCD genomics (LATINO): Study Protocol. medRxiv. 2023 Feb 26. PMID: 37131804; PMCID: PMC10153323.
      Citations:    
    48. Strouphauer ER, Morris OJ, Soileau KJ, Wiese AD, Quast T, Goodman WK, Sheth SA, Wojcik KD, Guzick AG, Storch EA. Economic Analyses of Obsessive-Compulsive Disorder Interventions: A Systematic Review. Pharmacoeconomics. 2023 05; 41(5):499-527. PMID: 36840747.
      Citations:    Fields:    Translation:Humans
    49. Xiao J, Provenza NR, Asfouri J, Myers J, Mathura RK, Metzger B, Adkinson JA, Allawala AB, Pirtle V, Oswalt D, Shofty B, Robinson ME, Mathew SJ, Goodman WK, Pouratian N, Schrater PR, Patel AB, Tolias AS, Bijanki KR, Pitkow X, Sheth SA. Decoding Depression Severity From Intracranial Neural Activity. Biol Psychiatry. 2023 09 15; 94(6):445-453. PMID: 36736418; PMCID: PMC10394110.
      Citations: 1     Fields:    Translation:Humans
    50. Gadot R, Li N, Shofty B, Avendano-Ortega M, McKay S, Bijanki KR, Robinson ME, Banks G, Provenza N, Storch EA, Goodman WK, Horn A, Sheth SA. Tractography-Based Modeling Explains Treatment Outcomes in Patients Undergoing Deep Brain Stimulation for Obsessive-Compulsive Disorder. Biol Psychiatry. 2024 Jul 15; 96(2):95-100. PMID: 36948900; PMCID: PMC10387502.
      Citations: 1     Fields:    
    51. Wong JK, Mayberg HS, Wang DD, Richardson RM, Halpern CH, Krinke L, Arlotti M, Rossi L, Priori A, Marceglia S, Gilron R, Cavanagh JF, Judy JW, Miocinovic S, Devergnas AD, Sillitoe RV, Cernera S, Oehrn CR, Gunduz A, Goodman WK, Petersen EA, Bronte-Stewart H, Raike RS, Malekmohammadi M, Greene D, Heiden P, Tan H, Volkmann J, Voon V, Li L, Sah P, Coyne T, Silburn PA, Kubu CS, Wexler A, Chandler J, Provenza NR, Heilbronner SR, Luciano MS, Rozell CJ, Fox MD, de Hemptinne C, Henderson JM, Sheth SA, Okun MS. Proceedings of the 10th annual deep brain stimulation think tank: Advances in cutting edge technologies, artificial intelligence, neuromodulation, neuroethics, interventional psychiatry, and women in neuromodulation. Front Hum Neurosci. 2022; 16:1084782. PMID: 36819295; PMCID: PMC9933515.
      Citations: 1     
    52. Abdallah CG, Sheth SA, Storch EA, Goodman WK. Brain Imaging in Psychiatry: Time to Move From Regions of Interest and Interpretive Analyses to Connectomes and Predictive Modeling? Am J Psychiatry. 2023 01 01; 180(1):17-19. PMID: 36587267.
      Citations:    Fields:    Translation:Humans
    53. Leong A, Colah ZA, Guzick AG, Chen EY, Shah SS, Fall DA, Chen R, Zhang Y, Zhang C, Cepeda SL, Weinzimmer SA, Schneider SC, Zhou X, Goodman WK, Liu W, Storch EA. COVID-19-related intrusive thoughts and associated ritualistic behaviors. Bull Menninger Clin. 2023; 87(3):225-249. PMID: 37695882.
      Citations: 1     Fields:    Translation:Humans
    54. Townsend AN, Guzick AG, Hertz AG, Kerns CM, Goodman WK, Berry LN, Kendall PC, Wood JJ, Storch EA. Anger Outbursts in Youth with ASD and Anxiety: Phenomenology and Relationship with Family Accommodation. Child Psychiatry Hum Dev. 2024 Oct; 55(5):1259-1268. PMID: 36576640; PMCID: PMC10300226.
      Citations: 1     Fields:    
    55. Guzick AG, Cervin M, Smith EEA, Clinger J, Draper I, Goodman WK, Lijffijt M, Murphy N, Lewin AB, Schneider SC, Storch EA. Clinical characteristics, impairment, and psychiatric morbidity in 102 youth with misophonia. J Affect Disord. 2023 03 01; 324:395-402. PMID: 36584703; PMCID: PMC9878468.
      Citations: 5     Fields:    Translation:Humans
    56. Spencer SD, Stiede JT, Wiese AD, Goodman WK, Guzick AG, Storch EA. Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder. Psychiatr Clin North Am. 2023 03; 46(1):167-180. PMID: 36740350; PMCID: PMC11170287.
      Citations:    Fields:    Translation:Humans
    57. Vazquez M, Palo A, Schuyler M, Small BJ, McGuire JF, Wilhelm S, Goodman WK, Geller D, Storch EA. The Relationship Between Adverse Childhood Experiences, Symptom Severity, Negative Thinking, Comorbidity, and Treatment Response in Youth with Obsessive-Compulsive Disorder. Child Psychiatry Hum Dev. 2024 Oct; 55(5):1201-1210. PMID: 36547756; PMCID: PMC10285027.
      Citations:    Fields:    
    58. Storch EA, Goodman WK. Obsessive Compulsive and Related Disorders. Psychiatr Clin North Am. 2023 03; 46(1):xiii-xv. PMID: 36740358.
      Citations:    Fields:    Translation:Humans
    59. Shofty B, Gadot R, Provenza N, Storch EA, Goodman WK, Sheth SA. Neurosurgical Approaches for Treatment-Resistant Obsessive-Compulsive Disorder. Psychiatr Clin North Am. 2023 03; 46(1):121-132. PMID: 36740348.
      Citations:    Fields:    Translation:Humans
    60. Shofty B, Gadot R, Viswanathan A, Provenza NR, Storch EA, McKay SA, Meyers MS, Hertz AG, Avendano-Ortega M, Goodman WK, Sheth SA. Intraoperative valence testing to adjudicate between ventral capsule/ventral striatum and bed nucleus of the stria terminalis target selection in deep brain stimulation for obsessive-compulsive disorder. J Neurosurg. 2023 08 01; 139(2):442-450. PMID: 36681982.
      Citations: 1     Fields:    
    61. Alarie ME, Provenza NR, Avendano-Ortega M, McKay SA, Waite AS, Mathura RK, Herron JA, Sheth SA, Borton DA, Goodman WK. Artifact characterization and mitigation techniques during concurrent sensing and stimulation using bidirectional deep brain stimulation platforms. Front Hum Neurosci. 2022; 16:1016379. PMID: 36337849; PMCID: PMC9626519.
      Citations:    
    62. Storch EA, Schneider SC, Olsen SM, Ramirez AC, Berry LN, Goin-Kochel RP, McNeel M, Candelari AE, Guzick AG, Cepeda SL, Weinzimmer S, Voigt RG, Quast T, Goodman WK, Salloum A. Stepped-Care Cognitive Behavioral Therapy in Children on the Autism Spectrum with Co-occurring Anxiety. J Autism Dev Disord. 2024 Jan; 54(1):93-108. PMID: 36239830; PMCID: PMC9561323.
      Citations: 2     Fields:    
    63. Chen P, Kim T, Dastin-van Rijn E, Provenza NR, Sheth SA, Goodman WK, Borton DA, Harrison MT, Darbon J. Periodic Artifact Removal With Applications to Deep Brain Stimulation. IEEE Trans Neural Syst Rehabil Eng. 2022; 30:2692-2699. PMID: 36121940; PMCID: PMC9553325.
      Citations:    
    64. Gadot R, Najera R, Hirani S, Anand A, Storch E, Goodman WK, Shofty B, Sheth SA. Efficacy of deep brain stimulation for treatment-resistant obsessive-compulsive disorder: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2022 Sep 20. PMID: 36127157.
      Citations:    
    65. Smith EEA, Guzick AG, Draper IA, Clinger J, Schneider SC, Goodman WK, Brout JJ, Lijffijt M, Storch EA. Perceptions of various treatment approaches for adults and children with misophonia. J Affect Disord. 2022 11 01; 316:76-82. PMID: 35970326; PMCID: PMC9884516.
      Citations:    
    66. L?zaro-Mu?oz G, Pham MT, Mu?oz KA, Kostick-Quenet K, Sanchez CE, Torgerson L, Robinson J, Pereira S, Outram S, Koenig BA, Starr PA, Gunduz A, Foote KD, Okun MS, Goodman W, McGuire AL, Zuk P. Post-trial access in implanted neural device research: Device maintenance, abandonment, and cost. Brain Stimul. 2022 Sep-Oct; 15(5):1029-1036. PMID: 35926784; PMCID: PMC9588741.
      Citations:    
    67. Najera RA, Gregory ST, Shofty B, Anand A, Gadot R, Youngerman BE, Storch EA, Goodman WK, Sheth SA. Cost-effectiveness analysis of radiosurgical capsulotomy versus treatment as usual for treatment-resistant obsessive-compulsive disorder. J Neurosurg. 2023 02 01; 138(2):347-357. PMID: 35907186.
      Citations:    Fields:    
    68. Dastin-van Rijn EM, Provenza NR, Vogt GS, Avendano-Ortega M, Sheth SA, Goodman WK, Harrison MT, Borton DA. PELP: Accounting for Missing Data in Neural Time Series by Periodic Estimation of Lost Packets. Front Hum Neurosci. 2022; 16:934063. PMID: 35874161; PMCID: PMC9301255.
      Citations:    
    69. Ahsan F, Chi T, Cho R, Sheth SA, Goodman W, Aazhang B. EMvelop stimulation: minimally invasive deep brain stimulation using temporally interfering electromagnetic waves. J Neural Eng. 2022 07 04; 19(4). PMID: 35700717.
      Citations:    Fields:    Translation:Humans
    70. Vogt GS, Schneider SC, Goodman WK, Storch EA, Avenda?o-Ortega M. Optimizing Obsessive-Compulsive Symptom Measurement With the Yale-Brown Obsessive-Compulsive Scales-Second Edition. J Psychiatr Pract. 2022 07 01; 28(4):294-309. PMID: 35797686; PMCID: PMC9393804.
      Citations:    Fields:    Translation:Humans
    71. Wiese AD, Drummond KN, Fuselier MN, Sheu JC, Liu G, Guzick AG, Goodman WK, Storch EA. Provider perceptions of telehealth and in-person exposure and response prevention for obsessive-compulsive disorder. Psychiatry Res. 2022 07; 313:114610. PMID: 35567851; PMCID: PMC9910090.
      Citations:    Fields:    Translation:HumansPHPublic Health
    72. Banks GP, Heilbronner SR, Goodman W, Sheth SA. A population-normalized tractographic fiber atlas of the anterior limb of the internal capsule: relevance to surgical neuromodulation. J Neurosurg. 2022 Nov 01; 137(5):1278-1288. PMID: 35395627.
      Citations:    Fields:    
    73. Weinzimmer SA, Goetz AR, Guzick AG, Hana LM, Cepeda SL, Schneider SC, Kennedy SM, Amos Nwankwo GN, Christian CC, Shaw AM, Salloum A, Shah AA, Goodman WK, Ehrenreich-May J, Storch EA. Primary Outcomes for Adults Receiving the Unified Protocol after Hurricane Harvey in an Integrated Healthcare Setting. Community Ment Health J. 2022 11; 58(8):1522-1534. PMID: 35377090; PMCID: PMC9962349.
      Citations:    Fields:    
    74. Adkinson JA, Tsolaki E, Sheth SA, Metzger BA, Robinson ME, Oswalt D, McIntyre CC, Mathura RK, Waters AC, Allawala AB, Noecker AM, Malekmohammadi M, Chiu K, Mustakos R, Goodman W, Borton D, Pouratian N, Bijanki KR. Imaging versus electrographic connectivity in human mood-related fronto-temporal networks. Brain Stimul. 2022 May-Jun; 15(3):554-565. PMID: 35292403; PMCID: PMC9232982.
      Citations:    Fields:    Translation:Humans
    75. Provenza NR, Gelin LFF, Mahaphanit W, McGrath MC, Dastin-van Rijn EM, Fan Y, Dhar R, Frank MJ, Restrepo MI, Goodman WK, Borton DA. Honeycomb: a template for reproducible psychophysiological tasks for clinic, laboratory, and home use. Braz J Psychiatry. 2022 Mar-Abr; 44(2):147-155. PMID: 34320125; PMCID: PMC9041958.
      Citations:    Fields:    Translation:Humans
    76. Maye CE, Wojcik KD, Candelari AE, Goodman WK, Storch EA. Obsessive compulsive disorder during the COVID-19 pandemic: A brief review of course, psychological assessment and treatment considerations. J Obsessive Compuls Relat Disord. 2022 Apr; 33:100722. PMID: 35194549; PMCID: PMC8855616.
      Citations:    
    77. Carmi L, Tendler A, Bystritsky A, Hollander E, Blumberger DM, Daskalakis J, Ward H, Lapidus K, Goodman W, Casuto L, Feifel D, Barnea-Ygael N, Roth Y, Zangen A, Zohar J. Efficacy and Safety of Deep Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: A Prospective Multicenter Randomized Double-Blind Placebo-Controlled Trial. Focus (Am Psychiatr Publ). 2022 Jan; 20(1):152-159. PMID: 35746941; PMCID: PMC9063595.
      Citations:    
    78. Guzick AG, Leong AW, Dickinson EM, Schneider SC, Zopatti K, Manis J, Meinert AC, Barth AM, Perez M, Campo DM, Weinzimmer SA, Cepeda SL, Mathai D, Shah A, Goodman WK, Salloum A, Kennedy S, Ehrenreich-May J, Storch EA. Brief, parent-led, transdiagnostic cognitive-behavioral teletherapy for youth with emotional problems related to the COVID-19 pandemic. J Affect Disord. 2022 Mar 15; 301:130-137. PMID: 35031335; PMCID: PMC8752168.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    79. Guzik AG, Schneider SC, Cepeda SL, Goodman WK, Storch EA, La Buissonni?re-Ariza V. Family Accommodation of Symptoms in Adults With Obsessive-Compulsive Disorder: Factor Structure and Usefulness of the Family Accommodation Scale for OCD-Patient Version. J Psychiatr Pract. 2022 01 06; 28(1):36-47. PMID: 34989343.
      Citations:    Fields:    Translation:Humans
    80. Grebe SC, Limon DL, McNeel MM, Guzick A, Peters SU, Tan WH, Sadhwani A, Bacino CA, Bird LM, Samaco RC, Berry LN, Goodman WK, Schneider SC, Storch EA. Anxiety in Angelman Syndrome. Am J Intellect Dev Disabil. 2022 01 01; 127(1):1-10. PMID: 34979033; PMCID: PMC8803540.
      Citations:    Fields:    Translation:Humans
    81. Gregory ST, Goodman WK, Kay B, Riemann B, Storch EA. Cost-effectiveness analysis of deep transcranial magnetic stimulation relative to evidence-based strategies for treatment-refractory obsessive-compulsive disorder. J Psychiatr Res. 2022 02; 146:50-54. PMID: 34953305.
      Citations:    Fields:    Translation:Humans
    82. Provenza NR, Sheth SA, Dastin-van Rijn EM, Mathura RK, Ding Y, Vogt GS, Avendano-Ortega M, Ramakrishnan N, Peled N, Gelin LFF, Xing D, Jeni LA, Ertugrul IO, Barrios-Anderson A, Matteson E, Wiese AD, Xu J, Viswanathan A, Harrison MT, Bijanki KR, Storch EA, Cohn JF, Goodman WK, Borton DA. Long-term ecological assessment of intracranial electrophysiology synchronized to behavioral markers in obsessive-compulsive disorder. Nat Med. 2021 12; 27(12):2154-2164. PMID: 34887577; PMCID: PMC8800455.
      Citations: 2     Fields:    Translation:Humans
    83. Barth AM, Meinert AC, Zopatti KL, Mathai D, Leong AW, Dickinson EM, Goodman WK, Shah AA, Schneider SC, Storch EA. A Qualitative Inquiry of Parents' Observations of Their Children's Mental Health Needs During the COVID-19 Pandemic. Child Health Care. 2022; 51(2):213-234. PMID: 35530015; PMCID: PMC9071000.
      Citations:    
    84. Sheth SA, Goodman W. Connectomic approaches to deep brain stimulation for OCD. Neuropsychopharmacology. 2022 03; 47(4):801-802. PMID: 34845310; PMCID: PMC8882179.
      Citations:    Fields:    Translation:Humans
    85. Sheth SA, Bijanki KR, Metzger B, Allawala A, Pirtle V, Adkinson JA, Myers J, Mathura RK, Oswalt D, Tsolaki E, Xiao J, Noecker A, Strutt AM, Cohn JF, McIntyre CC, Mathew SJ, Borton D, Goodman W, Pouratian N. Deep Brain Stimulation for Depression Informed by Intracranial Recordings. Biol Psychiatry. 2022 08 01; 92(3):246-251. PMID: 35063186; PMCID: PMC9124238.
      Citations:    Fields:    Translation:Humans
    86. Perez MI, Limon DL, Candelari AE, Cepeda SL, Ramirez AC, Guzick AG, Kook M, La Buissonniere Ariza V, Schneider SC, Goodman WK, Storch EA. Obsessive-Compulsive Disorder Misdiagnosis among Mental Healthcare Providers in Latin America. J Obsessive Compuls Relat Disord. 2022 Jan; 32. PMID: 34840937; PMCID: PMC8612600.
      Citations: 1     
    87. Pizzagalli DA, Smoski M, Ang YS, Whitton AE, Sanacora G, Mathew SJ, Nurnberger J, Lisanby SH, Iosifescu DV, Murrough JW, Yang H, Weiner RD, Calabrese JR, Goodman W, Potter WZ, Krystal AD. Correction to: Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS). Neuropsychopharmacology. 2021 Nov; 46(12):2224. PMID: 34389811; PMCID: PMC8505431.
      Citations:    Fields:    
    88. Allawala A, Bijanki KR, Goodman W, Cohn JF, Viswanathan A, Yoshor D, Borton DA, Pouratian N, Sheth SA. In Reply: A Novel Framework for Network-Targeted Neuropsychiatric Deep Brain Stimulation. Neurosurgery. 2021 10 13; 89(5):E283. PMID: 34383050; PMCID: PMC8510848.
      Citations: 1     Fields:    Translation:Humans
    89. Outram S, Kostick-Quenet K, Sanchez CE, Kalwani L, Lavingia R, Torgerson L, Sierra-Mercado D, Robinson JO, Pereira S, Koenig BA, Starr PA, Gunduz A, Foote KD, Okun MS, Goodman WK, McGuire AL, Zuk P, Mu?oz KA, L?zaro-Mu?oz G. Patient, Caregiver, and Decliner Perspectives on Whether to Enroll in Adaptive Deep Brain Stimulation Research. Front Neurosci. 2021; 15:734182. PMID: 34690676; PMCID: PMC8529029.
      Citations:    
    90. Guzick AG, Candelari A, Wiese AD, Schneider SC, Goodman WK, Storch EA. Obsessive-Compulsive Disorder During the COVID-19 Pandemic: a Systematic Review. Curr Psychiatry Rep. 2021 10 06; 23(11):71. PMID: 34613498; PMCID: PMC8493778.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    91. Vedam-Mai V, Deisseroth K, Giordano J, Lazaro-Munoz G, Chiong W, Suthana N, Langevin JP, Gill J, Goodman W, Provenza NR, Halpern CH, Shivacharan RS, Cunningham TN, Sheth SA, Pouratian N, Scangos KW, Mayberg HS, Johnson KA, Butson CR, Gilron R, de Hemptinne C, Wilt R, Yaroshinsky M, Little S, Starr P, Worrell G, Shirvalkar P, Chang E, Muthuraman M, Groppa S, Li L, Johnson M, Otto KJ, Raike R, Goetz S, Wu C, Silburn P, Cheeran B, Pathak YJ, Malekmohammadi M, Gunduz A, Wong JK, Cernera S, Hu W, Wagle Shukla A, Ramirez-Zamora A, Deeb W, Patterson A, Foote KD, Okun MS, Horn A, Volkmann J, K?hn AA. Corrigendum: Proceedings of the Eighth Annual Deep Brain Stimulation Think Tank: Advances in Optogenetics, Ethical Issues Affecting DBS Research, Neuromodulatory Approaches for Depression, Adaptive Neurostimulation, and Emerging DBS Technologies. Front Hum Neurosci. 2021; 15:765150. PMID: 34658825; PMCID: PMC8517517.
      Citations: 2     
    92. Ramakrishnan D, Levine JLS, Johnson JA, Artukoglu BB, Landeros-Weisenberger A, Cepeda SL, Comer JS, Franklin ME, Freeman JB, Geller DA, Grant PJ, Goodman WK, Heyman I, Ivarsson T, Lenhard F, Lewin AB, Li F, Merlo LJ, Mohsenabadi H, Peris TS, Piacentini J, Rozenman M, Sapyta JJ, Serlachius E, Shabani MJ, Small BJ, Skarphedinsson G, Swedo SE, Thomsen PH, Turner C, Weidle B, Storch EA, Mataix-Cols D, Bloch MH, Farhat LC, Vattimo EFQ, Asbahr FR, Fatori D, Rosa-Alc?zar AI, Rosa-Alc?zar ?, Shavitt RG, Miguel EC. Systematic Review and Meta-analysis: An Empirical Approach to Defining Treatment Response and Remission in Pediatric Obsessive-Compulsive Disorder. J Am Acad Child Adolesc Psychiatry. 2022 04; 61(4):495-507. PMID: 34597773.
      Citations: 1     Fields:    Translation:Humans
    93. Rasmussen SA, Goodman WK. The prefrontal cortex and neurosurgical treatment for intractable OCD. Neuropsychopharmacology. 2022 01; 47(1):349-360. PMID: 34433915; PMCID: PMC8616947.
      Citations:    Fields:    Translation:Humans
    94. Davis RA, Giordano J, Hufford DB, Sheth SA, Warnke P, Widge AS, Richardson RM, Rosenow JM, Rossi PJ, Storch EA, Winston H, Zboyan J, Dougherty DD, Foote KD, Goodman WK, McLaughlin NCR, Ojemann S, Rasmussen S, Abosch A, Okun MS. Restriction of Access to Deep Brain Stimulation for Refractory OCD: Failure to Apply the Federal Parity Act. Front Psychiatry. 2021; 12:706181. PMID: 34456762; PMCID: PMC8387630.
      Citations:    
    95. Allawala A, Bijanki KR, Goodman W, Cohn JF, Viswanathan A, Yoshor D, Borton DA, Pouratian N, Sheth SA. A Novel Framework for Network-Targeted Neuropsychiatric Deep Brain Stimulation. Neurosurgery. 2021 07 15; 89(2):E116-E121. PMID: 33913499; PMCID: PMC8279838.
      Citations: 8     Fields:    Translation:Humans
    96. McLaughlin NCR, Dougherty DD, Eskandar E, Ward H, Foote KD, Malone DA, Machado A, Wong W, Sedrak M, Goodman W, Kopell BH, Issa F, Shields DC, Abulseoud OA, Lee K, Frye MA, Widge AS, Deckersbach T, Okun MS, Bowers D, Bauer RM, Mason D, Kubu CS, Bernstein I, Lapidus K, Rosenthal DL, Jenkins RL, Read C, Malloy PF, Salloway S, Strong DR, Jones RN, Rasmussen SA, Greenberg BD. Double blind randomized controlled trial of deep brain stimulation for obsessive-compulsive disorder: Clinical trial design. Contemp Clin Trials Commun. 2021 Jun; 22:100785. PMID: 34189335; PMCID: PMC8219641.
      Citations: 1     
    97. Dastin-van Rijn EM, Provenza NR, Calvert JS, Gilron R, Allawala AB, Darie R, Syed S, Matteson E, Vogt GS, Avendano-Ortega M, Vasquez AC, Ramakrishnan N, Oswalt DN, Bijanki KR, Wilt R, Starr PA, Sheth SA, Goodman WK, Harrison MT, Borton DA. Uncovering biomarkers during therapeutic neuromodulation with PARRM: Period-based Artifact Reconstruction and Removal Method. Cell Rep Methods. 2021 06 21; 1(2). PMID: 34532716; PMCID: PMC8443190.
      Citations: 3     
    98. Peters ZV, Norwood LN, Modi HP, Goodman H, Yang PH, Coleman N, Monroe A, Goodman WK, Baylor College of Medicine Mental Health and Wellness Support Team, Storch EA. Addressing the mental health needs of learners and nonlearners in an academic medical center during COVID-19. Bull Menninger Clin. 2021; 85(3):283-297. PMID: 33939499.
      Citations:    Fields:    Translation:HumansCells
    99. Bijanki KR, Pathak YJ, Najera RA, Storch EA, Goodman WK, Simpson HB, Sheth SA. Defining functional brain networks underlying obsessive-compulsive disorder (OCD) using treatment-induced neuroimaging changes: a systematic review of the literature. J Neurol Neurosurg Psychiatry. 2021 07; 92(7):776-786. PMID: 33906936; PMCID: PMC8223624.
      Citations:    Fields:    Translation:Humans
    100. Vedam-Mai V, Deisseroth K, Giordano J, Lazaro-Munoz G, Chiong W, Suthana N, Langevin JP, Gill J, Goodman W, Provenza NR, Halpern CH, Shivacharan RS, Cunningham TN, Sheth SA, Pouratian N, Scangos KW, Mayberg HS, Johnson KA, Butson CR, Gilron R, de Hemptinne C, Wilt R, Yaroshinsky M, Little S, Starr P, Worrell G, Shirvalkar P, Chang E, Muthuraman M, Groppa S, Li L, Johnson M, Otto KJ, Raike R, Goetz S, Wu C, Silburn P, Cheeran B, Pathak YJ, Malekmohammadi M, Gunduz A, Wong JK, Cernera S, Hu W, Wagle Shukla A, Ramirez-Zamora A, Deeb W, Patterson A, Foote KD, Okun MS, Horn A, Volkmann J, K?hn AA. Proceedings of the Eighth Annual Deep Brain Stimulation Think Tank: Advances in Optogenetics, Ethical Issues Affecting DBS Research, Neuromodulatory Approaches for Depression, Adaptive Neurostimulation, and Emerging DBS Technologies. Front Hum Neurosci. 2021; 15:644593. PMID: 33953663; PMCID: PMC8092047.
      Citations: 8     
    101. Weinzimmer SA, Schneider SC, Cepeda SL, Guzick AG, McIngvale E, Goodman WK, Sheth SA, Storch EA, L?zaro-Mu?oz G. Perceptions of Deep Brain Stimulation for Adolescents with Obsessive-Compulsive Disorder. J Child Adolesc Psychopharmacol. 2021 03; 31(2):109-117. PMID: 33534637; PMCID: PMC7984933.
      Citations:    Fields:    Translation:Humans
    102. Lee EB, Rufino KA, Cuenod MM, Zhang CC, Gong H, Zhang Y, Jin H, Yang Y, Li B, Luo X, Liu W, Fang F, Li B, Sun X, Schneider SC, McIngvale E, Goodman WK, Storch EA. Family accommodation in Chinese individuals with obsessive-compulsive disorder. Psych J. 2021 Apr; 10(2):295-304. PMID: 33527703.
      Citations:    Fields:    Translation:Humans
    103. Lebowitz ER, Goodman WK, Storch EA, Iniesta-Sep?lveda M, Rodr?guez-Jim?nez T. The Relationship of Family Accommodation with Pediatric Anxiety Severity: Meta-analytic Findings and Child, Family and Methodological Moderators. Child Psychiatry Hum Dev. 2021 02; 52(1):1-14. PMID: 32246361.
      Citations: 2     Fields:    Translation:Humans
    104. Storch EA, Goodman WK. Response to: Optimizing DBS Stimulation Parameters in Obsessive-Compulsive Disorder. Neuromodulation. 2021 Feb; 24(2):400. PMID: 33605039.
      Citations:    Fields:    Translation:Humans
    105. Kim SK, McKay D, Murphy TK, Bussing R, McNamara JP, Goodman WK, Storch EA. Age moderated-anxiety mediation for multimodal treatment outcome among children with obsessive-compulsive disorder: An evaluation with correspondence analysis. J Affect Disord. 2021 03 01; 282:766-775. PMID: 33601717; PMCID: PMC9555304.
      Citations: 1     Fields:    Translation:Humans
    106. Goodman WK, Storch EA, Sheth SA. Harmonizing the Neurobiology and Treatment of Obsessive-Compulsive Disorder. Am J Psychiatry. 2021 01 01; 178(1):17-29. PMID: 33384007; PMCID: PMC8091795.
      Citations: 8     Fields:    Translation:Humans
    107. La Buissonniere-Ariza V, Fitzgerald K, Meoded A, Williams LL, Liu G, Goodman WK, Storch EA. Neural correlates of cognitive behavioral therapy response in youth with negative valence disorders: A systematic review of the literature. J Affect Disord. 2021 03 01; 282:1288-1307. PMID: 33601708.
      Citations: 2     Fields:    Translation:Humans
    108. Storch EA, Sheu JC, Guzick AG, Schneider SC, Cepeda SL, Rombado BR, Gupta R, Hoch CT, Goodman WK. Impact of the COVID-19 pandemic on exposure and response prevention outcomes in adults and youth with obsessive-compulsive disorder. Psychiatry Res. 2021 01; 295:113597. PMID: 33261922; PMCID: PMC7688422.
      Citations: 12     Fields:    Translation:Humans
    109. Storch EA, Tendler A, Schneider SC, Guzick AG, La Buissonniere-Ariza V, Goodman WK. Moderators and predictors of response to deep transcranial magnetic stimulation for obsessive-compulsive disorder. J Psychiatr Res. 2021 04; 136:508-514. PMID: 33218749.
      Citations: 2     Fields:    Translation:Humans
    110. Kostick K, Storch EA, Zuk P, Blumenthal-Barby JS, Torgerson L, Yoshor D, Sheth S, Viswanathan A, Tarakad A, Jimenez-Shahed J, Goodman W, L?zaro-Mu?oz G. Strategies to mitigate impacts of the COVID-19 pandemic on patients treated with deep brain stimulation. Brain Stimul. 2020 Nov - Dec; 13(6):1642-1643. PMID: 33017673; PMCID: PMC7530624.
      Citations: 3     Fields:    
    111. Ding Y, Ertugrul IO, Darzi A, Provenza N, Borton D, Goodman W, Cohn J, Jeni LA. Automated Detection of Enhanced DBS Device Settings. Companion Publ 2020 Int Conf Multimodal Interact. 2020 Oct; 2020:354-356. PMID: 33937916; PMCID: PMC8086638.
      Citations:    
    112. McCathern AG, Mathai DS, Cho RY, Goodman WK, Storch EA. Deep transcranial magnetic stimulation for obsessive compulsive disorder. Expert Rev Neurother. 2020 10; 20(10):1029-1036. PMID: 32684005.
      Citations: 2     Fields:    Translation:Humans
    113. McBride NM, Weinzimmer SA, Schneider SC, Ehrenreich May J, Lewin AB, McGuire JF, Goodman WK, Wood JJ, Storch EA, La Buissonni?re-Ariza V. The Impact of Comorbidity on Cognitive-Behavioral Therapy Response in Youth with Anxiety and Autism Spectrum Disorder. Child Psychiatry Hum Dev. 2020 08; 51(4):625-635. PMID: 32026260.
      Citations:    Fields:    Translation:Humans
    114. Larkin MB, McGinnis JP, Snyder RI, Storch EA, Goodman WK, Viswanathan A, Sheth SA. Neurostimulation for treatment-resistant posttraumatic stress disorder: an update on neurocircuitry and therapeutic targets. J Neurosurg. 2021 06 01; 134(6):1715-1723. PMID: 32736358.
      Citations: 1     Fields:    Translation:Humans
    115. Storch EA, Schneider SC, Guzick A, McKay D, Goodman WK. Impact of COVID-19 on exposure and response prevention for obsessive-compulsive disorder: Present and post-pandemic considerations. Psychiatry Res. 2020 10; 292:113310. PMID: 32707215; PMCID: PMC7367005.
      Citations: 8     Fields:    
    116. Storch EA, Peris TS, De Nadai A, Piacentini J, Bloch M, Cervin M, McGuire J, Farrell LJ, McCracken JT, McKay D, Riemann BC, Wagner AP, Franklin M, Schneider SC, Walkup JT, Williams L, Abramowitz JS, Stewart SE, Fitzgerald KD, Goodman WK. Little Doubt That CBT Works for Pediatric OCD. J Am Acad Child Adolesc Psychiatry. 2020 07; 59(7):785-787. PMID: 32618273.
      Citations: 1     Fields:    Translation:Humans
    117. Pizzagalli DA, Smoski M, Ang YS, Whitton AE, Sanacora G, Mathew SJ, Nurnberger J, Lisanby SH, Iosifescu DV, Murrough JW, Yang H, Weiner RD, Calabrese JR, Goodman W, Potter WZ, Krystal AD. Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS). Neuropsychopharmacology. 2020 09; 45(10):1656-1663. PMID: 32544925; PMCID: PMC7419512.
      Citations: 16     Fields:    Translation:Humans
    118. Goodman WK, Storch EA. Commentary: Duty to Warn: Antidepressant Black Box Suicidality Warning is Empirically Justified. Front Psychiatry. 2020; 11:363. PMID: 32477176; PMCID: PMC7233182.
      Citations:    
    119. Krystal AD, Pizzagalli DA, Smoski M, Mathew SJ, Nurnberger J, Lisanby SH, Iosifescu D, Murrough JW, Yang H, Weiner RD, Calabrese JR, Sanacora G, Hermes G, Keefe RSE, Song A, Goodman W, Szabo ST, Whitton AE, Gao K, Potter WZ. A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating ?-opioid antagonism as a treatment for anhedonia. Nat Med. 2020 05; 26(5):760-768. PMID: 32231295; PMCID: PMC9949770.
      Citations: 37     Fields:    Translation:Humans
    120. Lee EB, Goodman WK, Schneider SC, Storch EA. Parent-led Behavioral Intervention for a Treatment-refusing Adult With Obsessive-Compulsive Disorder With Poor Insight and Extreme Family Accommodation. J Psychiatr Pract. 2020 03; 26(2):149-152. PMID: 32134889; PMCID: PMC7197436.
      Citations: 1     Fields:    Translation:Humans
    121. Goodman WK, Storch EA, Cohn JF, Sheth SA. Deep Brain Stimulation for Intractable Obsessive-Compulsive Disorder: Progress and Opportunities. Am J Psychiatry. 2020 03 01; 177(3):200-203. PMID: 32114787; PMCID: PMC7239379.
      Citations: 1     Fields:    Translation:Humans
    122. Schneider SC, Knott L, Cepeda SL, Hana LM, McIngvale E, Goodman WK, Storch EA. Serious negative consequences associated with exposure and response prevention for obsessive-compulsive disorder: A survey of therapist attitudes and experiences. Depress Anxiety. 2020 05; 37(5):418-428. PMID: 32048376.
      Citations: 1     Fields:    Translation:Humans
    123. Guzick A, Hunt PJ, Bijanki KR, Schneider SC, Sheth SA, Goodman WK, Storch EA. Improving long term patient outcomes from deep brain stimulation for treatment-refractory obsessive-compulsive disorder. Expert Rev Neurother. 2020 01; 20(1):95-107. PMID: 31730752; PMCID: PMC7227118.
      Citations: 7     Fields:    Translation:Humans
    124. Zhang CC, Gong H, Zhang Y, Jin H, Yang Y, Li B, Li Y, Luo X, Liu W, Fang F, Li B, Sun B, Fletcher T, Goodman WK, Storch EA, La Buissonni?re-Ariza V. Development and psychometric evaluation of the Mandarin Chinese version of the Yale-Brown Obsessive-Compulsive Scale - Second Edition. Braz J Psychiatry. 2019 Nov-Dec; 41(6):494-498. PMID: 30785537; PMCID: PMC6899356.
      Citations: 2     Fields:    Translation:Humans
    125. Gregory ST, Kay B, Riemann BC, Goodman WK, Storch EA. Cost-Effectiveness of Treatment Alternatives for Treatment-Refractory Pediatric Obsessive-Compulsive Disorder. J Anxiety Disord. 2020 01; 69:102151. PMID: 31864218.
      Citations: 3     Fields:    Translation:Humans
    126. Rosenfield D, Smits JAJ, Hofmann SG, Mataix-Cols D, Andersson E, Monzani B, Frumento P, Davis M, de Kleine RA, Difede J, Dunlop BW, Farrell LJ, Geller D, Gerardi M, Guastella AJ, Hendriks GJ, Kushner MG, Lee FS, Lenze EJ, Levinson CA, McConnell H, Pollack MH, Ressler KJ, Rodebaugh TL, Rothbaum BO, Storch EA, Tart CD, Tolin DF, van Minnen A, Waters AM, Weems CF, Wilhelm S, Wyka K, Altemus M, Anderson P, Cukor J, Finck C, Geffken GR, Golfels F, Goodman WK, Gutner CA, Heyman I, Jovanovic T, Lewin AB, McNamara JP, Murphy TK, Norrholm S, Thuras P, Turner C, Otto MW, de la Cruz LF, R?ck C, P?rez-Vigil A, Plag J, Str?hle A. Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis. J Anxiety Disord. 2019 12; 68:102149. PMID: 31698111; PMCID: PMC9119697.
      Citations: 13     Fields:    Translation:Humans
    127. Sierra-Mercado D, Zuk P, Beauchamp MS, Sheth SA, Yoshor D, Goodman WK, McGuire AL, L?zaro-Mu?oz G. Device Removal Following Brain Implant Research. Neuron. 2019 09 04; 103(5):759-761. PMID: 31487526.
      Citations: 5     Fields:    Translation:Humans
    128. Perrin S, Aspvall K, Geller DA, Wilhelm S, McGuire J, Barcaccia B, Pozza A, Goodman WK, Murphy TK, Godoy A, Storch EA, Mataix-Cols D, Cervin M, Olsson E, L?zaro L, Mart?nez-Gonz?lez AE, Se?er I, Piqueras JA, Rodr?guez-Jim?nez T, Rosa-Alc?zar AI, Rosa-Alc?zar ?, Ruiz-Garc?a BM. The Centrality of Doubting and Checking in the Network Structure of Obsessive-Compulsive Symptom Dimensions in Youth. J Am Acad Child Adolesc Psychiatry. 2020 07; 59(7):880-889. PMID: 31421234; PMCID: PMC7219532.
      Citations: 8     Fields:    Translation:Humans
    129. Guzick AG, Cooke DL, McNamara JPH, Reid AM, Graziano PA, Lewin AB, Murphy TK, Goodman WK, Storch EA, Geffken GR. Parents' Perceptions of Internalizing and Externalizing Features in Childhood OCD. Child Psychiatry Hum Dev. 2019 08; 50(4):692-701. PMID: 30778711.
      Citations: 2     Fields:    Translation:Humans
    130. Zuk P, Pereira S, Kostick K, Torgerson L, Sierra-Mercado D, Majumder M, Blumenthal-Barby J, Storch EA, Goodman WK, McGuire AL, L?zaro-Mu?oz G. Neuroethics at 15: Keep the Kant but Add More Bacon. AJOB Neurosci. 2019 Jul-Sep; 10(3):97-100. PMID: 31329079; PMCID: PMC6666411.
      Citations: 3     Fields:    
    131. Schneider SC, Kay B, Riemann BC, Jacobi D, Eken S, Lake P, Nadeau J, Goodman WK, McIngvale E, Storch EA, H?jgaard DRMA, La Buissonni?re-Ariza V. Predictors of treatment outcome for youth receiving intensive residential treatment for obsessive-compulsive disorder (OCD). Cogn Behav Ther. 2020 07; 49(4):294-306. PMID: 31203735.
      Citations:    Fields:    Translation:Humans
    132. Carmi L, Tendler A, Bystritsky A, Hollander E, Blumberger DM, Daskalakis J, Ward H, Lapidus K, Goodman W, Casuto L, Feifel D, Barnea-Ygael N, Roth Y, Zangen A, Zohar J. Efficacy and Safety of Deep Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: A Prospective Multicenter Randomized Double-Blind Placebo-Controlled Trial. Am J Psychiatry. 2019 11 01; 176(11):931-938. PMID: 31109199.
      Citations: 49     Fields:    Translation:Humans
    133. Fang F, Zhang Y, Zhang LI, Jiang M, Song R, Wang YU, Wang Z, Li B, Farrell N, Cepeda SL, Schneider SC, McIngvale E, Shrestha S, Goodman WK, Zhang C, Storch EA. Chinese Therapists' Beliefs About Exposure Therapy for Anxiety and Obsessive-Compulsive Disorders. J Psychiatr Pract. 2019 05; 25(3):179-185. PMID: 31083029.
      Citations: 1     Fields:    Translation:Humans
    134. Zhang YY, Gong HF, Zhang XL, Liu WJ, Jin HY, Fang F, Schneider S, Mcingvale E, Zhang CC, Goodman WK, Sun XR, Storch EA. Incidence and clinical correlates of anger attacks in Chinese patients with obsessive-compulsive disorder. J Zhejiang Univ Sci B. 2019 Apr.; 20(4):363-370. PMID: 30932381; PMCID: PMC6454311.
      Citations:    Fields:    Translation:Humans
    135. Storch EA, Shah A, Salloum A, Valles N, Banu S, Schneider SC, Kaplow J, Goodman WK. Psychiatric Diagnoses and Medications for Hurricane Harvey Sheltered Evacuees. Community Ment Health J. 2019 10; 55(7):1099-1102. PMID: 30903533.
      Citations: 5     Fields:    Translation:Humans
    136. Davis ML, Fletcher T, McIngvale E, Cepeda SL, Schneider SC, Egberts J, Goodman W, Storch EA, La Buissonni?re Ariza V. Clinicians' perspectives of interfering behaviors in the treatment of anxiety and obsessive-compulsive disorders in adults and children. Cogn Behav Ther. 2020 01; 49(1):81-96. PMID: 30862251.
      Citations:    Fields:    Translation:Humans
    137. Provenza NR, Matteson ER, Allawala AB, Barrios-Anderson A, Sheth SA, Viswanathan A, McIngvale E, Storch EA, Frank MJ, McLaughlin NCR, Cohn JF, Goodman WK, Borton DA. The Case for Adaptive Neuromodulation to Treat Severe Intractable Mental Disorders. Front Neurosci. 2019; 13:152. PMID: 30890909; PMCID: PMC6412779.
      Citations: 19     
    138. Karas PJ, Lee S, Jimenez-Shahed J, Goodman WK, Viswanathan A, Sheth SA. Deep Brain Stimulation for Obsessive Compulsive Disorder: Evolution of Surgical Stimulation Target Parallels Changing Model of Dysfunctional Brain Circuits. Front Neurosci. 2018; 12:998. PMID: 30670945; PMCID: PMC6331476.
      Citations: 17     
    139. Krystal AD, Pizzagalli DA, Mathew SJ, Sanacora G, Keefe R, Song A, Calabrese J, Goddard A, Goodman W, Lisanby SH, Smoski M, Weiner R, Iosifescu D, Nurnberger J, Szabo S, Murrough J, Shekhar A, Potter W. The first implementation of the NIMH FAST-FAIL approach to psychiatric drug development. Nat Rev Drug Discov. 2018 12 28; 18(1):82-84. PMID: 30591715; PMCID: PMC6816017.
      Citations: 20     Fields:    Translation:Humans
    140. Brown C, Shahab R, Collins K, Fleysher L, Goodman WK, Burdick KE, Stern ER. Functional neural mechanisms of sensory phenomena in obsessive-compulsive disorder. J Psychiatr Res. 2019 02; 109:68-75. PMID: 30508745; PMCID: PMC6347462.
      Citations: 10     Fields:    Translation:Humans
    141. Storch EA, McGuire JF, Wu MS, Hamblin R, McIngvale E, Cepeda SL, Schneider SC, Rufino KA, Rasmussen SA, Price LH, Goodman WK. Development and Psychometric Evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale Second Edition. J Am Acad Child Adolesc Psychiatry. 2019 01; 58(1):92-98. PMID: 30577944; PMCID: PMC6309898.
      Citations: 9     Fields:    Translation:Humans
    142. Cohn JF, Okun MS, Jeni LA, Ertugrul IO, Borton D, Malone D, Goodman WK. Automated Affect Detection in Deep Brain Stimulation for Obsessive-Compulsive Disorder: A Pilot Study. Proc ACM Int Conf Multimodal Interact. 2018 Oct; 2018:40-44. PMID: 30511050; PMCID: PMC6271416.
      Citations: 6     
    143. Hildebrandt T, Schulz K, Schiller D, Heywood A, Goodman W, Sysko R. Evidence of prefrontal hyperactivation to food-cue reversal learning in adolescents with anorexia nervosa. Behav Res Ther. 2018 12; 111:36-43. PMID: 30292918.
      Citations: 7     Fields:    Translation:Humans
    144. Shameer K, Perez-Rodriguez MM, Bachar R, Li L, Johnson A, Johnson KW, Glicksberg BS, Smith MR, Readhead B, Scarpa J, Jebakaran J, Kovatch P, Lim S, Goodman W, Reich DL, Kasarskis A, Tatonetti NP, Dudley JT. Pharmacological risk factors associated with hospital readmission rates in a psychiatric cohort identified using prescriptome data mining. BMC Med Inform Decis Mak. 2018 09 14; 18(Suppl 3):79. PMID: 30255805; PMCID: PMC6156906.
      Citations: 3     Fields:    Translation:Humans
    145. Gosnell SN, Curtis KN, Velasquez K, Fowler JC, Madan A, Goodman W, Salas R. Habenular connectivity may predict treatment response in depressed psychiatric inpatients. J Affect Disord. 2019 01 01; 242:211-219. PMID: 30195174.
      Citations: 10     Fields:    Translation:HumansCells
    146. Stern ER, Shahab R, Grimaldi SJ, Leibu E, Murrough JW, Fleysher L, Parides MK, Coffey BJ, Burdick KE, Goodman WK. High-dose ondansetron reduces activation of interoceptive and sensorimotor brain regions. Neuropsychopharmacology. 2019 01; 44(2):390-398. PMID: 30116006; PMCID: PMC6300545.
      Citations: 8     Fields:    Translation:Humans
    147. Banneyer KN, Bonin L, Price K, Goodman WK, Storch EA. Cognitive Behavioral Therapy for Childhood Anxiety Disorders: a Review of Recent Advances. Curr Psychiatry Rep. 2018 07 28; 20(8):65. PMID: 30056623.
      Citations: 10     Fields:    Translation:Humans
    148. Yoshor D, Beauchamp MS, Goodman WK, McGuire AL, L?zaro-Mu?oz G. Continued access to investigational brain implants. Nat Rev Neurosci. 2018 06; 19(6):317-318. PMID: 29686310; PMCID: PMC6020153.
      Citations: 9     Fields:    Translation:Humans
    149. Cepeda SL, McKay D, Schneider SC, Egberts JTNE, McIngvale E, Goodman WK, Storch EA, La Buissonni?re-Ariza V. Politically-focused intrusive thoughts and associated ritualistic behaviors in a community sample. J Anxiety Disord. 2018 05; 56:35-42. PMID: 29631796.
      Citations:    Fields:    Translation:Humans
    150. Davis ML, McCann M, Goodman WK, Storch EA. Impact of the 2016 US presidential election on OCD symptom presentation: A case illustration. J Clin Psychol. 2018 05; 74(5):750-754. PMID: 29528496.
      Citations:    Fields:    Translation:Humans
    151. Bari AA, Mikell CB, Abosch A, Ben-Haim S, Buchanan RJ, Burton AW, Carcieri S, Cosgrove GR, D'Haese PF, Daskalakis ZJ, Eskandar EN, Gerrard JL, Goodman WK, Greenberg BD, Gross RE, Hamani C, Kiss ZHT, Konrad P, Kopell BH, Krinke L, Langevin JP, Lozano AM, Malone D, Mayberg HS, Miller JP, Patil PG, Peichel D, Petersen EA, Rezai AR, Richardson RM, Riva-Posse P, Sankar T, Schwalb JM, Simpson HB, Slavin K, Stypulkowski PH, Tosteson T, Warnke P, Willie JT, Zaghloul KA, Neimat JS, Pouratian N, Sheth SA. Charting the road forward in psychiatric neurosurgery: proceedings of the 2016 American Society for Stereotactic and Functional Neurosurgery workshop on neuromodulation for psychiatric disorders. J Neurol Neurosurg Psychiatry. 2018 08; 89(8):886-896. PMID: 29371415; PMCID: PMC7340367.
      Citations: 22     Fields:    Translation:Humans
    152. Ramirez-Zamora A, Giordano JJ, Gunduz A, Brown P, Sanchez JC, Foote KD, Almeida L, Starr PA, Bronte-Stewart HM, Hu W, McIntyre C, Goodman W, Kumsa D, Grill WM, Walker HC, Johnson MD, Vitek JL, Greene D, Rizzuto DS, Song D, Berger TW, Hampson RE, Deadwyler SA, Hochberg LR, Schiff ND, Stypulkowski P, Worrell G, Tiruvadi V, Mayberg HS, Jimenez-Shahed J, Nanda P, Sheth SA, Gross RE, Lempka SF, Li L, Deeb W, Okun MS. Evolving Applications, Technological Challenges and Future Opportunities in Neuromodulation: Proceedings of the Fifth Annual Deep Brain Stimulation Think Tank. Front Neurosci. 2017; 11:734. PMID: 29416498; PMCID: PMC5787550.
      Citations: 21     
    153. Shah AA, Valles N, Banu S, Storch EA, Goodman W. Meeting the Mental Health Needs of Hurricane Harvey Evacuees. Am J Psychiatry. 2018 Jan 01; 175(1):13-14. PMID: 29301425.
      Citations: 6     Fields:    Translation:Humans
    154. Stern ER, Grimaldi SJ, Muratore A, Murrough J, Leibu E, Fleysher L, Goodman WK, Burdick KE. Neural correlates of interoception: Effects of interoceptive focus and relationship to dimensional measures of body awareness. Hum Brain Mapp. 2017 12; 38(12):6068-6082. PMID: 28901713; PMCID: PMC5757871.
      Citations: 20     Fields:    Translation:Humans
    155. Rasgon A, Lee WH, Leibu E, Laird A, Glahn D, Goodman W, Frangou S. Neural correlates of affective and non-affective cognition in obsessive compulsive disorder: A meta-analysis of functional imaging studies. Eur Psychiatry. 2017 10; 46:25-32. PMID: 28992533.
      Citations:    
    156. McGuire AL, Goodman WK, L?zaro-Mu?oz G. Should we be concerned about preserving agency and personal identity in patients with Adaptive Deep Brain Stimulation systems? AJOB Neurosci. 2017; 8(2):73-75. PMID: 29238625; PMCID: PMC5725194.
      Citations: 4     Fields:    
    157. Mataix-Cols D, Monzani B, Rosenfield D, Andersson E, Frumento P, de Kleine RA, Difede J, Dunlop BW, Farrell LJ, Geller D, Gerardi M, Guastella AJ, Hofmann SG, Hendriks GJ, Kushner MG, Lee FS, Lenze EJ, Levinson CA, McConnell H, Otto MW, Pollack MH, Ressler KJ, Rodebaugh TL, Rothbaum BO, Scheeringa MS, Siewert-Siegmund A, Smits JAJ, Storch EA, Tart CD, Tolin DF, van Minnen A, Waters AM, Weems CF, Wilhelm S, Wyka K, Davis M, the DCS Anxiety Consortium, Altemus M, Anderson P, Cukor J, Geffken GR, Goodman WK, Gutner C, Heyman I, Jovanovic T, Lewin AB, McNamara JP, Murphy TK, Norrholm S, Thuras P, Fern?ndez de la Cruz L, P?rez-Vigil A, Plag J, Str?hle A, R?ck C, Finck C, Golfels F. D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data. JAMA Psychiatry. 2017 05 01; 74(5):501-510. PMID: 28122091.
      Citations: 62     Fields:    Translation:Humans
    158. Berlin HA, Stern ER, Ng J, Zhang S, Rosenthal D, Turetzky R, Tang C, Goodman W. Altered olfactory processing and increased insula activity in patients with obsessive-compulsive disorder: An fMRI study. Psychiatry Res Neuroimaging. 2017 Apr 30; 262:15-24. PMID: 28208068; PMCID: PMC5373557.
      Citations: 10     Fields:    Translation:Humans
    159. Fayad SM, Guzick AG, Reid AM, Mason DM, Bertone A, Foote KD, Okun MS, Goodman WK, Ward HE. Six-Nine Year Follow-Up of Deep Brain Stimulation for Obsessive-Compulsive Disorder. PLoS One. 2016; 11(12):e0167875. PMID: 27930748; PMCID: PMC5145226.
      Citations: 14     Fields:    Translation:Humans
    160. Guzick AG, McNamara JPH, Reid AM, Balkhi AM, Storch EA, Murphy TK, Goodman WK, Bussing R, Geffken GR. The link between ADHD-like inattention and obsessions and compulsions during treatment of youth with OCD. J Obsessive Compuls Relat Disord. 2017 Jan; 12:1-8. PMID: 28966908; PMCID: PMC5619255.
      Citations: 3     
    161. Stern ER, Muratore AF, Taylor SF, Abelson JL, Hof PR, Goodman WK. Switching between internally and externally focused attention in obsessive-compulsive disorder: Abnormal visual cortex activation and connectivity. Psychiatry Res Neuroimaging. 2017 Jul 30; 265:87-97. PMID: 28024845; PMCID: PMC5316503.
      Citations: 12     Fields:    Translation:Humans
    162. Rosenthal DL, Leibu E, Aloysi AS, Kopell BH, Goodman WK, Kellner CH. Safety and efficacy of electroconvulsive therapy for depression in the presence of deep brain stimulation in obsessive-compulsive disorder. J Clin Psychiatry. 2016 05; 77(5):689-90. PMID: 27249078.
      Citations: 2     Fields:    Translation:Humans
    163. O'Halloran R, Kopell BH, Sprooten E, Goodman WK, Frangou S. Multimodal Neuroimaging-Informed Clinical Applications in Neuropsychiatric Disorders. Front Psychiatry. 2016; 7:63. PMID: 27148092; PMCID: PMC4835492.
      Citations: 8     
    164. Rossi PJ, Gunduz A, Judy J, Wilson L, Machado A, Giordano JJ, Elias WJ, Rossi MA, Butson CL, Fox MD, McIntyre CC, Pouratian N, Swann NC, de Hemptinne C, Gross RE, Chizeck HJ, Tagliati M, Lozano AM, Goodman W, Langevin JP, Alterman RL, Akbar U, Gerhardt GA, Grill WM, Hallett M, Herrington T, Herron J, van Horne C, Kopell BH, Lang AE, Lungu C, Martinez-Ramirez D, Mogilner AY, Molina R, Opri E, Otto KJ, Oweiss KG, Pathak Y, Shukla A, Shute J, Sheth SA, Shih LC, Steinke GK, Vanegas N, Zaghloul KA, Cendejas-Zaragoza L, Verhagen L, Foote KD, Okun MS, Tr?ster AI. Proceedings of the Third Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and Technologies. Front Neurosci. 2016; 10:119. PMID: 27092042; PMCID: PMC4821860.
      Citations: 16     
    165. Ely BA, Xu J, Goodman WK, Lapidus KA, Gabbay V, Stern ER. Resting-state functional connectivity of the human habenula in healthy individuals: Associations with subclinical depression. Hum Brain Mapp. 2016 07; 37(7):2369-84. PMID: 26991474; PMCID: PMC4905808.
      Citations: 31     Fields:    Translation:Humans
    166. Kim JW, Naidich TP, Ely BA, Yacoub E, De Martino F, Fowkes ME, Goodman WK, Xu J. Human habenula segmentation using myelin content. Neuroimage. 2016 Apr 15; 130:145-156. PMID: 26826517.
      Citations: 14     Fields:    Translation:HumansCells
    167. Lujan JL, Chaturvedi A, Goodman WK, Okun MS, McIntyre CC, Haq IU, Hartmann CJ. Tractography Activation Patterns in Dorsolateral Prefrontal Cortex Suggest Better Clinical Responses in OCD DBS. Front Neurosci. 2015; 9:519. PMID: 26834544; PMCID: PMC4717315.
      Citations: 30     
    168. Reid AM, McNamara JP, Murphy TK, Guzick AG, Storch EA, Goodman WK, Geffken GR, Bussing R. Side-effects of SSRIs disrupt multimodal treatment for pediatric OCD in a randomized-controlled trial. J Psychiatr Res. 2015 Dec; 71:140-7. PMID: 26495770; PMCID: PMC4653063.
      Citations: 8     Fields:    Translation:Humans
    169. Berlin HA, Schulz KP, Zhang S, Turetzky R, Rosenthal D, Goodman W. Neural correlates of emotional response inhibition in obsessive-compulsive disorder: A preliminary study. Psychiatry Res. 2015 Nov 30; 234(2):259-64. PMID: 26456416.
      Citations: 12     Fields:    Translation:Humans
    170. Murrough JW, Soleimani L, DeWilde KE, Collins KA, Lapidus KA, Iacoviello BM, Lener M, Kautz M, Kim J, Stern JB, Price RB, Perez AM, Brallier JW, Rodriguez GJ, Goodman WK, Iosifescu DV, Charney DS. Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial. Psychol Med. 2015 Dec; 45(16):3571-80. PMID: 26266877.
      Citations:    
    171. Denys D, Goodman W, Greenberg BD, Jimenez-Ponce F, Kuhn J, Lenartz D, Mallet L, Nuttin B, Schuurman R, Alonso P, Cuadras D, Gabri?ls L, Real E, Segalas C, du Montcel ST, Menchon JM. Deep Brain Stimulation for Obsessive-Compulsive Disorder: A Meta-Analysis of Treatment Outcome and Predictors of Response. PLoS One. 2015; 10(7):e0133591. PMID: 26208305; PMCID: PMC4514753.
      Citations: 68     Fields:    Translation:Humans
    172. Hildebrandt T, Grotzinger A, Reddan M, Greif R, Levy I, Goodman W, Schiller D. Testing the disgust conditioning theory of food-avoidance in adolescents with recent onset anorexia nervosa. Behav Res Ther. 2015 Aug; 71:131-8. PMID: 26131915.
      Citations:    
    173. Gunduz A, Morita H, Rossi PJ, Allen WL, Alterman RL, Bronte-Stewart H, Butson CR, Charles D, Deckers S, de Hemptinne C, DeLong M, Dougherty D, Ellrich J, Foote KD, Giordano J, Goodman W, Greenberg BD, Greene D, Gross R, Judy JW, Karst E, Kent A, Kopell B, Lang A, Lozano A, Lungu C, Lyons KE, Machado A, Martens H, McIntyre C, Min HK, Neimat J, Ostrem J, Pannu S, Ponce F, Pouratian N, Reymers D, Schrock L, Sheth S, Shih L, Stanslaski S, Steinke GK, Stypulkowski P, Verhagen L, Walker H, Okun MS, Tr?ster AI. Proceedings of the Second Annual Deep Brain Stimulation Think Tank: What's in the Pipeline. Int J Neurosci. 2015; 125(7):475-85. PMID: 25526555; PMCID: PMC4743588.
      Citations: 8     Fields:    Translation:HumansAnimals
    174. Goodman WK, Grice DE, Lapidus KA, Coffey BJ. Obsessive-compulsive disorder. Psychiatr Clin North Am. 2014 Sep; 37(3):257-67. PMID: 25150561.
      Citations: 31     Fields:    Translation:HumansAnimals
    175. Goodman WK. Obsessive compulsive and related disorders. Psychiatr Clin North Am. 2014 Sep; 37(3):xi-xii. PMID: 25150571.
      Citations: 1     Fields:    Translation:Humans
    176. Lapidus KA, Stern ER, Berlin HA, Goodman WK. Neuromodulation for obsessive-compulsive disorder. Neurotherapeutics. 2014 Jul; 11(3):485-95. PMID: 24981434; PMCID: PMC4121444.
      Citations: 13     Fields:    Translation:Humans
    177. Stern ER, Muratore AF, Taylor SF, Abelson JL, Hof PR, Goodman WK. The Persistence of Experience: Prior Attentional and Emotional State Affects Network Functioning in a Target Detection Task. Cereb Cortex. 2015 Sep; 25(9):3235-48. PMID: 24904075; PMCID: PMC4537450.
      Citations: 3     Fields:    Translation:Humans
    178. Garnaat SL, Greenberg BD, Sibrava NJ, Goodman WK, Mancebo MC, Eisen JL, Rasmussen SA. Who qualifies for deep brain stimulation for OCD? Data from a naturalistic clinical sample. J Neuropsychiatry Clin Neurosci. 2014; 26(1):81-6. PMID: 24515679; PMCID: PMC4093791.
      Citations: 17     Fields:    Translation:Humans
    179. Morishita T, Fayad SM, Goodman WK, Foote KD, Chen D, Peace DA, Rhoton AL, Okun MS. Surgical neuroanatomy and programming in deep brain stimulation for obsessive compulsive disorder. Neuromodulation. 2014 Jun; 17(4):312-9; discussion 319. PMID: 24345303; PMCID: PMC4061279.
      Citations: 15     Fields:    Translation:Humans
    180. Storch EA, Bussing R, Small BJ, Geffken GR, McNamara JP, Rahman O, Lewin AB, Garvan CS, Goodman WK, Murphy TK. Randomized, placebo-controlled trial of cognitive-behavioral therapy alone or combined with sertraline in the treatment of pediatric obsessive-compulsive disorder. Behav Res Ther. 2013 Dec; 51(12):823-9. PMID: 24184429; PMCID: PMC3908957.
      Citations: 22     Fields:    Translation:Humans
    181. Hogendoorn SM, de Haan E, Wolters LH, Vervoort L, Prins PJ, de Bourgraaf A, Scheerman NA, Nauta MH, Hartman CA, Boer F, Goodman WK. The anxiety severity interview for children and adolescents: an individualized repeated measure of anxiety severity. Clin Psychol Psychother. 2014 Nov-Dec; 21(6):525-35. PMID: 24000105.
      Citations:    Fields:    Translation:Humans
    182. Storch EA, Goddard AW, Grant JE, De Nadai AS, Goodman WK, Mutch PJ, Medlock C, Odlaug B, McDougle CJ, Murphy TK. Double-blind, placebo-controlled, pilot trial of paliperidone augmentation in serotonin reuptake inhibitor-resistant obsessive-compulsive disorder. J Clin Psychiatry. 2013 Jun; 74(6):e527-32. PMID: 23842022.
      Citations: 9     Fields:    Translation:Humans
    183. Bloch MH, Green C, Kichuk SA, Dombrowski PA, Wasylink S, Billingslea E, Landeros-Weisenberger A, Kelmendi B, Goodman WK, Leckman JF, Coric V, Pittenger C. Long-term outcome in adults with obsessive-compulsive disorder. Depress Anxiety. 2013 Aug; 30(8):716-22. PMID: 23532944; PMCID: PMC3932438.
      Citations: 13     Fields:    Translation:Humans
    184. Lapidus KA, Kopell BH, Ben-Haim S, Rezai AR, Goodman WK. History of psychosurgery: a psychiatrist's perspective. World Neurosurg. 2013 Sep-Oct; 80(3-4):S27.e1-16. PMID: 23419707.
      Citations: 12     Fields:    Translation:Humans
    185. Okun MS, Foote KD, Wu SS, Ward HE, Bowers D, Rodriguez RL, Malaty IA, Goodman WK, Gilbert DM, Walker HC, Mink JW, Merritt S, Morishita T, Sanchez JC. A trial of scheduled deep brain stimulation for Tourette syndrome: moving away from continuous deep brain stimulation paradigms. JAMA Neurol. 2013 Jan; 70(1):85-94. PMID: 23044532.
      Citations: 44     Fields:    Translation:Humans
    186. Bussing R, Murphy TK, Storch EA, McNamara JP, Reid AM, Garvan CW, Goodman WK. Psychometric properties of the Treatment-Emergent Activation and Suicidality Assessment Profile (TEASAP) in youth with OCD. Psychiatry Res. 2013 Feb 28; 205(3):253-61. PMID: 23031804; PMCID: PMC3540123.
      Citations: 9     Fields:    Translation:Humans
    187. Vora AK, Ward H, Foote KD, Goodman WK, Okun MS. Rebound symptoms following battery depletion in the NIH OCD DBS cohort: clinical and reimbursement issues. Brain Stimul. 2012 Oct; 5(4):599-604. PMID: 22305344.
      Citations:    
    188. Goodman WK, Alterman RL. Deep brain stimulation for intractable psychiatric disorders. Annu Rev Med. 2012; 63:511-24. PMID: 22034866.
      Citations: 23     Fields:    Translation:Humans
    189. Murphy TK, Storch EA, Lewin AB, Edge PJ, Goodman WK. Clinical factors associated with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. J Pediatr. 2012 Feb; 160(2):314-9. PMID: 21868033; PMCID: PMC3227761.
      Citations: 39     Fields:    Translation:HumansCells
    190. McGuire JF, Storch EA, Lewin AB, Price LH, Rasmussen SA, Goodman WK. The role of avoidance in the phenomenology of obsessive-compulsive disorder. Compr Psychiatry. 2012 Feb; 53(2):187-94. PMID: 21550030.
      Citations: 13     Fields:    Translation:Humans
    191. Storch EA, Murphy TK, Goodman WK, Geffken GR, Lewin AB, Henin A, Micco JA, Sprich S, Wilhelm S, Bengtson M, Geller DA. A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder. Biol Psychiatry. 2010 Dec 01; 68(11):1073-6. PMID: 20817153; PMCID: PMC3034091.
      Citations: 59     Fields:    Translation:Humans
    192. Lewin AB, De Nadai AS, Park J, Goodman WK, Murphy TK, Storch EA. Refining clinical judgment of treatment outcome in obsessive-compulsive disorder. Psychiatry Res. 2011 Feb 28; 185(3):394-401. PMID: 20846725.
      Citations: 23     Fields:    Translation:Humans
    193. Haq IU, Foote KD, Goodman WK, Ricciuti N, Ward H, Sudhyadhom A, Jacobson CE, Siddiqui MS, Okun MS. A case of mania following deep brain stimulation for obsessive compulsive disorder. Stereotact Funct Neurosurg. 2010; 88(5):322-8. PMID: 20714212; PMCID: PMC2969111.
      Citations: 23     Fields:    Translation:Humans
    194. Meyer RE, Salzman C, Youngstrom EA, Clayton PJ, Goodwin FK, Mann JJ, Alphs LD, Broich K, Goodman WK, Greden JF, Meltzer HY, Normand SL, Posner K, Shaffer D, Oquendo MA, Stanley B, Trivedi MH, Turecki G, Beasley CM, Beautrais AL, Bridge JA, Brown GK, Revicki DA, Ryan ND, Sheehan DV. Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement. J Clin Psychiatry. 2010 Aug; 71(8):e1-e21. PMID: 20797373.
      Citations: 32     Fields:    Translation:Humans
    195. Meyer RE, Salzman C, Youngstrom EA, Clayton PJ, Goodwin FK, Mann JJ, Alphs LD, Broich K, Goodman WK, Greden JF, Meltzer HY, Normand SL, Posner K, Shaffer D, Oquendo MA, Stanley B, Trivedi MH, Turecki G, Beasley CM, Beautrais AL, Bridge JA, Brown GK, Revicki DA, Ryan ND, Sheehan DV. Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief report. J Clin Psychiatry. 2010 Aug; 71(8):1040-6. PMID: 20673551.
      Citations: 11     Fields:    Translation:Humans
    196. Triggs WJ, Ricciuti N, Ward HE, Cheng J, Bowers D, Goodman WK, Kluger BM, Nadeau SE. Right and left dorsolateral pre-frontal rTMS treatment of refractory depression: a randomized, sham-controlled trial. Psychiatry Res. 2010 Aug 15; 178(3):467-74. PMID: 20643486.
      Citations: 15     Fields:    Translation:HumansCTClinical Trials
    197. Storch EA, Rasmussen SA, Price LH, Larson MJ, Murphy TK, Goodman WK. Development and psychometric evaluation of the Yale-Brown Obsessive-Compulsive Scale--Second Edition. Psychol Assess. 2010 Jun; 22(2):223-32. PMID: 20528050.
      Citations: 37     Fields:    Translation:Humans
    198. Leckman JF, Denys D, Simpson HB, Mataix-Cols D, Hollander E, Saxena S, Miguel EC, Rauch SL, Goodman WK, Phillips KA, Stein DJ. Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V. Depress Anxiety. 2010 Jun; 27(6):507-27. PMID: 20217853; PMCID: PMC3974619.
      Citations: 76     Fields:    Translation:Humans
    199. Storch EA, Larson MJ, Price LH, Rasmussen SA, Murphy TK, Goodman WK. Psychometric analysis of the Yale-Brown Obsessive-Compulsive Scale Second Edition Symptom Checklist. J Anxiety Disord. 2010 Aug; 24(6):650-6. PMID: 20471199.
      Citations: 8     Fields:    Translation:Humans
    200. Haq IU, Foote KD, Goodman WG, Wu SS, Sudhyadhom A, Ricciuti N, Siddiqui MS, Bowers D, Jacobson CE, Ward H, Okun MS. Smile and laughter induction and intraoperative predictors of response to deep brain stimulation for obsessive-compulsive disorder. Neuroimage. 2011 Jan; 54 Suppl 1:S247-55. PMID: 20226259; PMCID: PMC2907450.
      Citations: 31     Fields:    Translation:Humans
    201. Burdick A, Foote KD, Goodman W, Ward HE, Ricciuti N, Murphy T, Haq I, Okun MS. Lack of benefit of accumbens/capsular deep brain stimulation in a patient with both tics and obsessive-compulsive disorder. Neurocase. 2010 Aug; 16(4):321-30. PMID: 20178034.
      Citations: 22     Fields:    Translation:Humans
    202. Goodman WK, Foote KD, Greenberg BD, Ricciuti N, Bauer R, Ward H, Shapira NA, Wu SS, Hill CL, Rasmussen SA, Okun MS. Deep brain stimulation for intractable obsessive compulsive disorder: pilot study using a blinded, staggered-onset design. Biol Psychiatry. 2010 Mar 15; 67(6):535-42. PMID: 20116047; PMCID: PMC5796545.
      Citations: 104     Fields:    Translation:HumansCTClinical Trials
    203. Reid JM, Storch EA, Murphy TK, Bodzin D, Mutch PJ, Lehmkuhl H, Aman M, Goodman WK. Development and Psychometric Evaluation of the Treatment-Emergent Activation and Suicidality Assessment Profile. Child Youth Care Forum. 2010 Feb 04; 39(2):113-124. PMID: 20473344; PMCID: PMC2867356.
      Citations: 5     
    204. Merlo LJ, Storch EA, Lehmkuhl HD, Jacob ML, Murphy TK, Goodman WK, Geffken GR. Cognitive behavioral therapy plus motivational interviewing improves outcome for pediatric obsessive-compulsive disorder: a preliminary study. Cogn Behav Ther. 2010; 39(1):24-7. PMID: 19675960; PMCID: PMC2861340.
      Citations: 14     Fields:    Translation:Humans
    205. Landeros-Weisenberger A, Bloch MH, Kelmendi B, Wegner R, Nudel J, Dombrowski P, Pittenger C, Krystal JH, Goodman WK, Leckman JF, Coric V. Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder. J Affect Disord. 2010 Feb; 121(1-2):175-9. PMID: 19577308; PMCID: PMC3974618.
      Citations: 26     Fields:    Translation:Humans
    206. Storch EA, Khanna M, Merlo LJ, Loew BA, Franklin M, Reid JM, Goodman WK, Murphy TK. Children's Florida Obsessive Compulsive Inventory: psychometric properties and feasibility of a self-report measure of obsessive-compulsive symptoms in youth. Child Psychiatry Hum Dev. 2009 Sep; 40(3):467-83. PMID: 19326209.
      Citations: 26     Fields:    Translation:Humans
    207. Lack CW, Storch EA, Keeley ML, Geffken GR, Ricketts ED, Murphy TK, Goodman WK. Quality of life in children and adolescents with obsessive-compulsive disorder: base rates, parent-child agreement, and clinical correlates. Soc Psychiatry Psychiatr Epidemiol. 2009 Nov; 44(11):935-42. PMID: 19255701.
      Citations: 42     Fields:    Translation:Humans
    208. Goodman WK, Insel TR. Deep brain stimulation in psychiatry: concentrating on the road ahead. Biol Psychiatry. 2009 Feb 15; 65(4):263-6. PMID: 19167964.
      Citations: 16     Fields:    Translation:Humans
    209. Burdick A, Goodman WK, Foote KD. Deep brain stimulation for refractory obsessive-compulsive disorder. Front Biosci (Landmark Ed). 2009 01 01; 14(5):1880-90. PMID: 19273170.
      Citations: 10     Fields:    Translation:Humans
    210. Goldstein RB, Storch EA, Lehmkuhl H, Geffken GR, Goodman WK, Murphy TK. Successful medication withdrawal after cognitive-behavioral therapy in a treatment-resistant preadolescent male with obsessive-compulsive disorder. Depress Anxiety. 2009; 26(1):E23-5. PMID: 19067320.
      Citations: 1     Fields:    Translation:Humans
    211. Sulkowski ML, Storch EA, Geffken GR, Ricketts E, Murphy TK, Goodman WK. Concurrent validity of the Yale-Brown Obsessive-Compulsive Scale-Symptom Checklist. J Clin Psychol. 2008 Dec; 64(12):1338-51. PMID: 18942133.
      Citations: 4     Fields:    Translation:Humans
    212. Wang PS, Heinssen R, Oliveri M, Wagner A, Goodman W. Bridging bench and practice: translational research for schizophrenia and other psychotic disorders. Neuropsychopharmacology. 2009 Jan; 34(1):204-12. PMID: 18830238.
      Citations: 4     Fields:    Translation:HumansAnimals
    213. Brady LS, Winsky L, Goodman W, Oliveri ME, Stover E. NIMH initiatives to facilitate collaborations among industry, academia, and government for the discovery and clinical testing of novel models and drugs for psychiatric disorders. Neuropsychopharmacology. 2009 Jan; 34(1):229-43. PMID: 18800066; PMCID: PMC2917632.
      Citations: 4     Fields:    Translation:HumansAnimals
    214. Stewart SE, Rosario MC, Baer L, Carter AS, Brown TA, Scharf JM, Illmann C, Leckman JF, Sukhodolsky D, Katsovich L, Rasmussen S, Goodman W, Delorme R, Leboyer M, Chabane N, Jenike MA, Geller DA, Pauls DL. Four-factor structure of obsessive-compulsive disorder symptoms in children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry. 2008 Jul; 47(7):763-772. PMID: 18520961.
      Citations: 25     Fields:    Translation:Humans
    215. Storch EA, Milsom VA, Merlo LJ, Larson M, Geffken GR, Jacob ML, Murphy TK, Goodman WK. Insight in pediatric obsessive-compulsive disorder: associations with clinical presentation. Psychiatry Res. 2008 Aug 15; 160(2):212-20. PMID: 18556071.
      Citations: 26     Fields:    Translation:Humans
    216. Greenberg BD, Gabriels LA, Malone DA, Rezai AR, Friehs GM, Okun MS, Shapira NA, Foote KD, Cosyns PR, Kubu CS, Malloy PF, Salloway SP, Giftakis JE, Rise MT, Machado AG, Baker KB, Stypulkowski PH, Goodman WK, Rasmussen SA, Nuttin BJ. Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience. Mol Psychiatry. 2010 Jan; 15(1):64-79. PMID: 18490925; PMCID: PMC3790898.
      Citations:    
    217. Aldea MA, Geffken GR, Jacob ML, Goodman WK, Storch EA. Further psychometric analysis of the Florida Obsessive-Compulsive Inventory. J Anxiety Disord. 2009 Jan; 23(1):124-9. PMID: 18571371.
      Citations: 7     Fields:    Translation:Humans
    218. Storch EA, Merlo LJ, Larson MJ, Geffken GR, Lehmkuhl HD, Jacob ML, Murphy TK, Goodman WK. Impact of comorbidity on cognitive-behavioral therapy response in pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 2008 May; 47(5):583-592. PMID: 18356759.
      Citations: 57     Fields:    Translation:Humans
    219. Murphy TK, Segarra A, Storch EA, Goodman WK. SSRI adverse events: how to monitor and manage. Int Rev Psychiatry. 2008 Apr; 20(2):203-8. PMID: 18386213.
      Citations: 22     Fields:    Translation:Humans
    220. Storch EA, McNamara J, Jordan C, Marien WE, Jacob ML, Murphy TK, Goodman WK, Geffken GR. Associations between miscellaneous symptoms and symptom dimensions in adults with obsessive-compulsive disorder. Anxiety Stress Coping. 2008 Apr; 21(2):199-212. PMID: 18350397.
      Citations: 2     Fields:    Translation:Humans
    221. George MS, Ward HE, Ninan PT, Pollack M, Nahas Z, Anderson B, Kose S, Howland RH, Goodman WK, Ballenger JC. A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders. Brain Stimul. 2008 Apr; 1(2):112-21. PMID: 20633378.
      Citations: 50     Fields:    Translation:Humans
    222. Gallant J, Storch EA, Merlo LJ, Ricketts ED, Geffken GR, Goodman WK, Murphy TK. Convergent and discriminant validity of the Children's Yale-Brown Obsessive Compulsive Scale-Symptom Checklist. J Anxiety Disord. 2008 Dec; 22(8):1369-76. PMID: 18329843.
      Citations: 19     Fields:    Translation:Humans
    223. Okun MS, Fernandez HH, Foote KD, Murphy TK, Goodman WK. Avoiding deep brain stimulation failures in Tourette syndrome. J Neurol Neurosurg Psychiatry. 2008 Feb; 79(2):111-2. PMID: 18202200.
      Citations: 6     Fields:    Translation:Humans
    224. Storch EA, Abramowitz J, Goodman WK. Where does obsessive-compulsive disorder belong in DSM-V? Depress Anxiety. 2008; 25(4):336-47. PMID: 18412060.
      Citations: 17     Fields:    Translation:Humans
    225. Storch EA, Stigge-Kaufman D, Marien WE, Sajid M, Jacob ML, Geffken GR, Goodman WK, Murphy TK. Obsessive-compulsive disorder in youth with and without a chronic tic disorder. Depress Anxiety. 2008; 25(9):761-7. PMID: 17345600.
      Citations: 5     Fields:    Translation:Humans
    226. Storch EA, Merlo LJ, Lehmkuhl H, Geffken GR, Jacob M, Ricketts E, Murphy TK, Goodman WK. Cognitive-behavioral therapy for obsessive-compulsive disorder: a non-randomized comparison of intensive and weekly approaches. J Anxiety Disord. 2008 Oct; 22(7):1146-58. PMID: 18242950.
      Citations: 9     Fields:    Translation:Humans
    227. Goodman WK, Lydiard RB. Recognition and treatment of obsessive-compulsive disorder. J Clin Psychiatry. 2007 Dec; 68(12):e30. PMID: 18162010.
      Citations: 6     Fields:    Translation:Humans
    228. Storch EA, Merlo LJ, Larson MJ, Bloss CS, Geffken GR, Jacob ML, Murphy TK, Goodman WK. Symptom dimensions and cognitive-behavioural therapy outcome for pediatric obsessive-compulsive disorder. Acta Psychiatr Scand. 2008 Jan; 117(1):67-75. PMID: 17986317.
      Citations: 15     Fields:    Translation:Humans
    229. Storch EA, Murphy TK, Lack CW, Geffken GR, Jacob ML, Goodman WK. Sleep-related problems in pediatric obsessive-compulsive disorder. J Anxiety Disord. 2008 Jun; 22(5):877-85. PMID: 17951025; PMCID: PMC2413417.
      Citations: 32     Fields:    Translation:Humans
    230. Storch EA, Kaufman DA, Bagner D, Merlo LJ, Shapira NA, Geffken GR, Murphy TK, Goodman WK. Florida Obsessive-Compulsive Inventory: development, reliability, and validity. J Clin Psychol. 2007 Sep; 63(9):851-9. PMID: 17674398.
      Citations: 29     Fields:    Translation:Humans
    231. Storch EA, Merlo LJ, Larson MJ, Marien WE, Geffken GR, Jacob ML, Goodman WK, Murphy TK. Clinical features associated with treatment-resistant pediatric obsessive-compulsive disorder. Compr Psychiatry. 2008 Jan-Feb; 49(1):35-42. PMID: 18063039.
      Citations: 12     Fields:    Translation:Humans
    232. Storch EA, Merlo LJ, Bengtson M, Murphy TK, Lewis MH, Yang MC, Jacob ML, Larson M, Hirsh A, Fernandez M, Geffken GR, Goodman WK. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder. Int Clin Psychopharmacol. 2007 Jul; 22(4):230-7. PMID: 17519647.
      Citations: 60     Fields:    Translation:Humans
    233. Storch EA, Lack C, Merlo LJ, Marien WE, Geffken GR, Grabill K, Jacob ML, Murphy TK, Goodman WK. Associations between miscellaneous symptoms and symptom dimensions: an examination of pediatric obsessive-compulsive disorder. Behav Res Ther. 2007 Nov; 45(11):2593-603. PMID: 17644061.
      Citations: 5     Fields:    Translation:Humans
    234. Storch EA, Lack CW, Merlo LJ, Geffken GR, Jacob ML, Murphy TK, Goodman WK. Clinical features of children and adolescents with obsessive-compulsive disorder and hoarding symptoms. Compr Psychiatry. 2007 Jul-Aug; 48(4):313-8. PMID: 17560950.
      Citations: 30     Fields:    Translation:Humans
    235. Storch EA, Lack CW, Simons LE, Goodman WK, Murphy TK, Geffken GR. A measure of functional impairment in youth with Tourette's syndrome. J Pediatr Psychol. 2007 Sep; 32(8):950-9. PMID: 17522110.
      Citations: 51     Fields:    Translation:Humans
    236. Storch EA, Geffken GR, Merlo LJ, Jacob ML, Murphy TK, Goodman WK, Larson MJ, Fernandez M, Grabill K. Family accommodation in pediatric obsessive-compulsive disorder. J Clin Child Adolesc Psychol. 2007 Apr-Jun; 36(2):207-16. PMID: 17484693.
      Citations: 76     Fields:    Translation:Humans
    237. Storch EA, Merlo LJ, Lack C, Milsom VA, Geffken GR, Goodman WK, Murphy TK. Quality of life in youth with Tourette's syndrome and chronic tic disorder. J Clin Child Adolesc Psychol. 2007 Apr-Jun; 36(2):217-27. PMID: 17484694.
      Citations: 52     Fields:    Translation:Humans
    238. Storch EA, Geffken GR, Merlo LJ, Mann G, Duke D, Munson M, Adkins J, Grabill KM, Murphy TK, Goodman WK. Family-based cognitive-behavioral therapy for pediatric obsessive-compulsive disorder: comparison of intensive and weekly approaches. J Am Acad Child Adolesc Psychiatry. 2007 Apr; 46(4):469-478. PMID: 17420681.
      Citations: 76     Fields:    Translation:Humans
    239. Storch EA, Bagner DM, Geffken GR, Adkins JW, Murphy TK, Goodman WK. Sequential cognitive-behavioral therapy for children with obsessive-compulsive disorder with an inadequate medication response: a case series of five patients. Depress Anxiety. 2007; 24(6):375-81. PMID: 17044015.
      Citations: 6     Fields:    Translation:Humans
    240. Goodman WK, Murphy TK, Storch EA. Risk of adverse behavioral effects with pediatric use of antidepressants. Psychopharmacology (Berl). 2007 Mar; 191(1):87-96. PMID: 17180618.
      Citations: 18     Fields:    Translation:Humans
    241. Storch EA, Murphy TK, Fernandez M, Krishnan M, Geffken GR, Kellgren AR, Goodman WK. Factor-analytic study of the Yale Global Tic Severity Scale. Psychiatry Res. 2007 Jan 15; 149(1-3):231-7. PMID: 17150256.
      Citations: 18     Fields:    Translation:Humans
    242. Storch EA, Merlo LJ, Lehmkuhl H, Grabill KM, Geffken GR, Goodman WK, Murphy TK. Further psychometric examination of the Tourette's Disorder Scales. Child Psychiatry Hum Dev. 2007 Aug; 38(2):89-98. PMID: 17136450.
      Citations: 4     Fields:    Translation:Humans
    243. Murphy TK, Snider LA, Mutch PJ, Harden E, Zaytoun A, Edge PJ, Storch EA, Yang MC, Mann G, Goodman WK, Swedo SE. Relationship of movements and behaviors to Group A Streptococcus infections in elementary school children. Biol Psychiatry. 2007 Feb 01; 61(3):279-84. PMID: 17126304.
      Citations: 21     Fields:    Translation:HumansCells
    244. Storch EA, Murphy TK, Geffken GR, Mann G, Adkins J, Merlo LJ, Duke D, Munson M, Swaine Z, Goodman WK. Cognitive-behavioral therapy for PANDAS-related obsessive-compulsive disorder: findings from a preliminary waitlist controlled open trial. J Am Acad Child Adolesc Psychiatry. 2006 Oct; 45(10):1171-8. PMID: 17003662.
      Citations: 18     Fields:    Translation:HumansCells
    245. Okun MS, Mann G, Foote KD, Shapira NA, Bowers D, Springer U, Knight W, Martin P, Goodman WK. Deep brain stimulation in the internal capsule and nucleus accumbens region: responses observed during active and sham programming. J Neurol Neurosurg Psychiatry. 2007 Mar; 78(3):310-4. PMID: 17012341; PMCID: PMC2117652.
      Citations: 46     Fields:    Translation:Humans
    246. Storch EA, Ledley DR, Lewin AB, Murphy TK, Johns NB, Goodman WK, Geffken GR. Peer victimization in children with obsessive-compulsive disorder: relations with symptoms of psychopathology. J Clin Child Adolesc Psychol. 2006 Sep; 35(3):446-55. PMID: 16836482.
      Citations: 19     Fields:    Translation:Humans
    247. Goodman WK, Storch EA, Geffken GR, Murphy TK. Obsessive-compulsive disorder in Tourette syndrome. J Child Neurol. 2006 Aug; 21(8):704-14. PMID: 16970872.
      Citations: 10     Fields:    Translation:Humans
    248. Husted DS, Shapira NA, Murphy TK, Mann GD, Ward HE, Goodman WK. Effect of comorbid tics on a clinically meaningful response to 8-week open-label trial of fluoxetine in obsessive compulsive disorder. J Psychiatr Res. 2007 Apr-Jun; 41(3-4):332-7. PMID: 16860338.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    249. Greenberg BD, Malone DA, Friehs GM, Rezai AR, Kubu CS, Malloy PF, Salloway SP, Okun MS, Goodman WK, Rasmussen SA. Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology. 2006 Nov; 31(11):2384-93. PMID: 16855529.
      Citations: 194     Fields:    Translation:HumansCTClinical Trials
    250. Skidmore FM, Rodriguez RL, Fernandez HH, Goodman WK, Foote KD, Okun MS. Lessons learned in deep brain stimulation for movement and neuropsychiatric disorders. CNS Spectr. 2006 Jul; 11(7):521-36. PMID: 16816792.
      Citations: 11     Fields:    Translation:Humans
    251. Springer US, Bowers D, Goodman WK, Shapira NA, Foote KD, Okun MS. Long-term habituation of the smile response with deep brain stimulation. Neurocase. 2006 Jun; 12(3):191-6. PMID: 16801154; PMCID: PMC7063676.
      Citations: 11     Fields:    Translation:Humans
    252. Murphy TK, Sajid MW, Goodman WK. Immunology of obsessive-compulsive disorder. Psychiatr Clin North Am. 2006 Jun; 29(2):445-69. PMID: 16650717.
      Citations: 16     Fields:    Translation:Humans
    253. Hirsh A, O'Brien K, Geffken GR, Adkins J, Goodman WK, Storch EA. Cognitive-behavioral treatment for obsessive-compulsive disorder in an elderly male with concurrent medical constraints. Am J Geriatr Psychiatry. 2006 Apr; 14(4):380-1. PMID: 16582047.
      Citations: 1     Fields:    Translation:Humans
    254. Shapira NA, Okun MS, Wint D, Foote KD, Byars JA, Bowers D, Springer US, Lang PJ, Greenberg BD, Haber SN, Goodman WK. Panic and fear induced by deep brain stimulation. J Neurol Neurosurg Psychiatry. 2006 Mar; 77(3):410-2. PMID: 16484657; PMCID: PMC2077710.
      Citations:    
    255. Lewin AB, Storch EA, Geffken GR, Goodman WK, Murphy TK. A neuropsychiatric review of pediatric obsessive-compulsive disorder: etiology and efficacious treatments. Neuropsychiatr Dis Treat. 2006 Mar; 2(1):21-31. PMID: 19412443; PMCID: PMC2671737.
      Citations: 10     
    256. Storch EA, Murphy TK, Adkins JW, Lewin AB, Geffken GR, Johns NB, Jann KE, Goodman WK. The children's Yale-Brown obsessive-compulsive scale: psychometric properties of child- and parent-report formats. J Anxiety Disord. 2006; 20(8):1055-70. PMID: 16503111.
      Citations: 40     Fields:    Translation:Humans
    257. Husted DS, Shapira NA, Goodman WK. The neurocircuitry of obsessive-compulsive disorder and disgust. Prog Neuropsychopharmacol Biol Psychiatry. 2006 May; 30(3):389-99. PMID: 16443315.
      Citations: 21     Fields:    Translation:HumansAnimals
    258. Storch EA, Larson MJ, Shapira NA, Ward HE, Murphy TK, Geffken GR, Valerio H, Goodman WK. Clinical predictors of early fluoxetine treatment response in obsessive-compulsive disorder. Depress Anxiety. 2006; 23(7):429-33. PMID: 16841343.
      Citations: 9     Fields:    Translation:Humans
    259. Storch EA, Murphy TK, Geffken GR, Sajid M, Allen P, Roberti JW, Goodman WK. Reliability and validity of the Yale Global Tic Severity Scale. Psychol Assess. 2005 Dec; 17(4):486-91. PMID: 16393016.
      Citations: 68     Fields:    Translation:Humans
    260. Geffken GR, Storch EA, Duke DC, Monaco L, Lewin AB, Goodman WK. Hope and coping in family members of patients with obsessive-compulsive disorder. J Anxiety Disord. 2006; 20(5):614-29. PMID: 16084686.
      Citations: 15     Fields:    Translation:Humans
    261. Goodman WK, Bose A, Wang Q. Treatment of generalized anxiety disorder with escitalopram: pooled results from double-blind, placebo-controlled trials. J Affect Disord. 2005 Aug; 87(2-3):161-7. PMID: 15982747.
      Citations: 20     Fields:    Translation:Humans
    262. Storch EA, Murphy TK, Bagner DM, Johns NB, Baumeister AL, Goodman WK, Geffken GR. Reliability and validity of the Child Behavior Checklist Obsessive-Compulsive Scale. J Anxiety Disord. 2006; 20(4):473-85. PMID: 16046257.
      Citations: 12     Fields:    Translation:Humans
    263. Byerly M, Goodman W, Acholonu W, Bugno R, Rush AJ. Obsessive compulsive symptoms in schizophrenia: frequency and clinical features. Schizophr Res. 2005 Jul 15; 76(2-3):309-16. PMID: 15949663.
      Citations: 20     Fields:    Translation:Humans
    264. Storch EA, Murphy TK, Geffken GR, Bagner DM, Soto O, Sajid M, Allen P, Killiany EM, Goodman WK. Factor analytic study of the Children's Yale-Brown Obsessive-Compulsive Scale. J Clin Child Adolesc Psychol. 2005 Jun; 34(2):312-9. PMID: 15901231.
      Citations: 14     Fields:    Translation:Humans
    265. Stein DJ, Andersen HF, Goodman WK. Escitalopram for the treatment of GAD: efficacy across different subgroups and outcomes. Ann Clin Psychiatry. 2005 Apr-Jun; 17(2):71-5. PMID: 16075659.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    266. Merlo LJ, Storch EA, Murphy TK, Goodman WK, Geffken GR. Assessment of pediatric obsessive-compulsive disorder: a critical review of current methodology. Child Psychiatry Hum Dev. 2005; 36(2):195-214. PMID: 16228147.
      Citations: 8     Fields:    Translation:Humans
    267. Storch EA, Shapira NA, Dimoulas E, Geffken GR, Murphy TK, Goodman WK. Yale-Brown Obsessive Compulsive Scale: the dimensional structure revisited. Depress Anxiety. 2005; 22(1):28-35. PMID: 16130118.
      Citations: 12     Fields:    Translation:Humans
    268. Geffken GR, Storch EA, Gelfand KM, Adkins JW, Goodman WK. Cognitive-behavioral therapy for obsessive-compulsive disorder: review of treatment techniques. J Psychosoc Nurs Ment Health Serv. 2004 Dec; 42(12):44-51. PMID: 15633304.
      Citations: 1     Fields:    Translation:Humans
    269. Storch EA, Murphy TK, Geffken GR, Soto O, Sajid M, Allen P, Roberti JW, Killiany EM, Goodman WK. Psychometric evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale. Psychiatry Res. 2004 Nov 30; 129(1):91-8. PMID: 15572188.
      Citations: 90     Fields:    Translation:Humans
    270. Okun MS, Bowers D, Springer U, Shapira NA, Malone D, Rezai AR, Nuttin B, Heilman KM, Morecraft RJ, Rasmussen SA, Greenberg BD, Foote KD, Goodman WK. What's in a "smile?" Intra-operative observations of contralateral smiles induced by deep brain stimulation. Neurocase. 2004 Aug; 10(4):271-9. PMID: 15788264; PMCID: PMC7098684.
      Citations: 34     Fields:    Translation:Humans
    271. Culpepper L, Davidson JR, Dietrich AJ, Goodman WK, Kroenke K, Schwenk TL. Suicidality as a possible side effect of antidepressant treatment. J Clin Psychiatry. 2004 Jun; 65(6):742-9. PMID: 15291649.
      Citations: 9     Fields:    Translation:Humans
    272. Shapira NA, Ward HE, Mandoki M, Murphy TK, Yang MC, Blier P, Goodman WK. A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorder. Biol Psychiatry. 2004 Mar 01; 55(5):553-5. PMID: 15023585.
      Citations: 20     Fields:    Translation:HumansCTClinical Trials
    273. Murphy TK, Sajid M, Soto O, Shapira N, Edge P, Yang M, Lewis MH, Goodman WK. Detecting pediatric autoimmune neuropsychiatric disorders associated with streptococcus in children with obsessive-compulsive disorder and tics. Biol Psychiatry. 2004 Jan 01; 55(1):61-8. PMID: 14706426.
      Citations: 32     Fields:    Translation:Humans
    274. Goodman WK. Selecting pharmacotherapy for generalized anxiety disorder. J Clin Psychiatry. 2004; 65 Suppl 13:8-13. PMID: 15384931.
      Citations: 6     Fields:    Translation:Humans
    275. Storch EA, Murphy TK, Geffken GR, Soto O, Sajid M, Allen P, Roberti JW, Killiany EM, Goodman WK. Further psychometric properties of the Tourette's Disorder Scale-Parent Rated version (TODS-PR). Child Psychiatry Hum Dev. 2004; 35(2):107-20. PMID: 15577277.
      Citations: 8     Fields:    Translation:Humans
    276. Pallanti S, Hollander E, Goodman WK. A qualitative analysis of nonresponse: management of treatment-refractory obsessive-compulsive disorder. J Clin Psychiatry. 2004; 65 Suppl 14:6-10. PMID: 15554782.
      Citations: 12     Fields:    Translation:Humans
    277. Culpepper L, Davidson JR, Dietrich AJ, Goodman WK, Kroenke K, Schwenk TL. Suicidality as a Possible Side Effect of Antidepressant Treatment. Prim Care Companion J Clin Psychiatry. 2004; 6(2):79-86. PMID: 15254601; PMCID: PMC427603.
      Citations: 8     
    278. Shapira NA, Liu Y, He AG, Bradley MM, Lessig MC, James GA, Stein DJ, Lang PJ, Goodman WK. Brain activation by disgust-inducing pictures in obsessive-compulsive disorder. Biol Psychiatry. 2003 Oct 01; 54(7):751-6. PMID: 14512216.
      Citations: 67     Fields:    Translation:Humans
    279. Hollander E, Koran LM, Goodman WK, Greist JH, Ninan PT, Yang H, Li D, Barbato LM. A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder. J Clin Psychiatry. 2003 Jun; 64(6):640-7. PMID: 12823077.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    280. Nadeau SE, McCoy KJ, Crucian GP, Greer RA, Rossi F, Bowers D, Goodman WK, Heilman KM, Triggs WJ. Cerebral blood flow changes in depressed patients after treatment with repetitive transcranial magnetic stimulation: evidence of individual variability. Neuropsychiatry Neuropsychol Behav Neurol. 2002 Sep; 15(3):159-75. PMID: 12218709.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    281. Mataix-Cols D, Rauch SL, Baer L, Eisen JL, Shera DM, Goodman WK, Rasmussen SA, Jenike MA. Symptom stability in adult obsessive-compulsive disorder: data from a naturalistic two-year follow-up study. Am J Psychiatry. 2002 Feb; 159(2):263-8. PMID: 11823269.
      Citations: 54     Fields:    Translation:Humans
    282. Murphy T, Goodman W. Genetics of childhood disorders: XXXIV. Autoimmune disorders, part 7: D8/17 reactivity as an immunological marker of susceptibility to neuropsychiatric disorders. J Am Acad Child Adolesc Psychiatry. 2002 Jan; 41(1):98-100. PMID: 11800215.
      Citations: 2     Fields:    Translation:HumansCells
    283. Murphy TK, Benson N, Zaytoun A, Yang M, Braylan R, Ayoub E, Goodman WK. Progress toward analysis of D8/17 binding to B cells in children with obsessive compulsive disorder and/or chronic tic disorder. J Neuroimmunol. 2001 Nov 01; 120(1-2):146-51. PMID: 11694329.
      Citations: 4     Fields:    Translation:HumansCells
    284. Murphy TK, Petitto JM, Voeller KK, Goodman WK. Obsessive compulsive disorder: is there an association with childhood streptococcal infections and altered immune function? Semin Clin Neuropsychiatry. 2001 Oct; 6(4):266-76. PMID: 11607922.
      Citations: 5     Fields:    Translation:Humans
    285. Stein DJ, Liu Y, Shapira NA, Goodman WK. The psychobiology of obsessive-compulsive disorder: how important is the role of disgust? Curr Psychiatry Rep. 2001 Aug; 3(4):281-7. PMID: 11470034.
      Citations: 11     Fields:    Translation:Humans
    286. Romano S, Goodman W, Tamura R, Gonzales J. Long-term treatment of obsessive-compulsive disorder after an acute response: a comparison of fluoxetine versus placebo. J Clin Psychopharmacol. 2001 Feb; 21(1):46-52. PMID: 11199947.
      Citations: 14     Fields:    Translation:HumansCTClinical Trials
    287. Stein DJ, Goodman WK, Rauch SL. The cognitive-affective neuroscience of obsessive-compulsive disorder. Curr Psychiatry Rep. 2000 Aug; 2(4):341-6. PMID: 11122979.
      Citations: 14     Fields:    Translation:Humans
    288. Murphy TK, Goodman WK, Ayoub EM, Voeller KK. On defining Sydenham's chorea: where do we draw the line? Biol Psychiatry. 2000 May 15; 47(10):851-7. PMID: 10807957.
      Citations: 9     Fields:    Translation:Humans
    289. Morris MR, Forbes S, Bradley MM, Goodman WK. Stability of subclinical obsessive compulsive disorder in college students. Depress Anxiety. 2000; 11(4):180-2. PMID: 10945139.
      Citations:    Fields:    Translation:Humans
    290. Alsobrook II JP, Leckman JF, Goodman WK, Rasmussen SA, Pauls DL. Segregation analysis of obsessive-compulsive disorder using symptom-based factor scores. Am J Med Genet. 1999 Dec 15; 88(6):669-75. PMID: 10581488.
      Citations: 27     Fields:    Translation:Humans
    291. van Wattum PJ, Anderson GM, Chappell PB, Goodman WK, Riddle MA, Leckman JF. Cerebrospinal fluid dynorphin A[1-8] and beta-endorphin levels in Tourette's syndrome are unaltered. Biol Psychiatry. 1999 Jun 01; 45(11):1527-8. PMID: 10356639.
      Citations:    Fields:    Translation:Humans
    292. Triggs WJ, McCoy KJ, Greer R, Rossi F, Bowers D, Kortenkamp S, Nadeau SE, Heilman KM, Goodman WK. Effects of left frontal transcranial magnetic stimulation on depressed mood, cognition, and corticomotor threshold. Biol Psychiatry. 1999 Jun 01; 45(11):1440-6. PMID: 10356626.
      Citations: 34     Fields:    Translation:HumansCTClinical Trials
    293. Eisen JL, Goodman WK, Keller MB, Warshaw MG, DeMarco LM, Luce DD, Rasmussen SA. Patterns of remission and relapse in obsessive-compulsive disorder: a 2-year prospective study. J Clin Psychiatry. 1999 May; 60(5):346-51; quiz 352. PMID: 10362449.
      Citations: 42     Fields:    Translation:HumansCTClinical Trials
    294. Goddard AW, Woods SW, Money R, Pande AC, Charney DS, Goodman WK, Heninger GR, Price LH. Effects of the CCK(B) antagonist CI-988 on responses to mCPP in generalized anxiety disorder. Psychiatry Res. 1999 Mar 22; 85(3):225-40. PMID: 10333376.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    295. Goodman WK. Obsessive-compulsive disorder: diagnosis and treatment. J Clin Psychiatry. 1999; 60 Suppl 18:27-32. PMID: 10487253.
      Citations: 11     Fields:    Translation:Humans
    296. McDougle CJ, Barr LC, Goodman WK, Price LH. Possible role of neuropeptides in obsessive compulsive disorder. Psychoneuroendocrinology. 1999 Jan; 24(1):1-24. PMID: 10098217.
      Citations: 11     Fields:    Translation:HumansAnimals
    297. Barr LC, Goodman WK, Anand A, McDougle CJ, Price LH. Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder. Am J Psychiatry. 1997 Sep; 154(9):1293-5. PMID: 9286191.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    298. Leckman JF, Grice DE, Boardman J, Zhang H, Vitale A, Bondi C, Alsobrook J, Peterson BS, Cohen DJ, Rasmussen SA, Goodman WK, McDougle CJ, Pauls DL. Symptoms of obsessive-compulsive disorder. Am J Psychiatry. 1997 Jul; 154(7):911-7. PMID: 9210740.
      Citations: 98     Fields:    Translation:Humans
    299. Scahill L, Riddle MA, McSwiggin-Hardin M, Ort SI, King RA, Goodman WK, Cicchetti D, Leckman JF. Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry. 1997 Jun; 36(6):844-52. PMID: 9183141.
      Citations: 609     Fields:    Translation:Humans
    300. Barr LC, Heninger GR, Goodman W, Charney DS, Price LH. Effects of fluoxetine administration on mood response to tryptophan depletion in healthy subjects. Biol Psychiatry. 1997 May 01; 41(9):949-54. PMID: 9110100.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    301. Murphy TK, Goodman WK, Fudge MW, Williams RC, Ayoub EM, Dalal M, Lewis MH, Zabriskie JB. B lymphocyte antigen D8/17: a peripheral marker for childhood-onset obsessive-compulsive disorder and Tourette's syndrome? Am J Psychiatry. 1997 Mar; 154(3):402-7. PMID: 9054790.
      Citations: 13     Fields:    Translation:HumansCells
    302. Rasmusson AM, Anderson GM, Lynch KA, McSwiggan-Hardin M, Scahill LD, Mazure CM, Goodman WK, Price LH, Cohen DJ, Leckman JF. A preliminary study of tryptophan depletion on tics, obsessive-compulsive symptoms, and mood in Tourette's syndrome. Biol Psychiatry. 1997 Jan 01; 41(1):117-21. PMID: 8988803.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    303. Phillips KA, Hollander E, Rasmussen SA, Aronowitz BR, DeCaria C, Goodman WK. A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale. Psychopharmacol Bull. 1997; 33(1):17-22. PMID: 9133747.
      Citations: 183     Fields:    Translation:HumansCTClinical Trials
    304. Goodman WK, Ward H, Kablinger A, Murphy T. Fluvoxamine in the treatment of obsessive-compulsive disorder and related conditions. J Clin Psychiatry. 1997; 58 Suppl 5:32-49. PMID: 9184625.
      Citations: 7     Fields:    Translation:Humans
    305. Jenike MA, Rauch SL, Cummings JL, Savage CR, Goodman WK. Recent developments in neurobiology of obsessive-compulsive disorder. J Clin Psychiatry. 1996 Oct; 57(10):492-503. PMID: 8909341.
      Citations: 2     Fields:    Translation:Humans
    306. Byerly MJ, Goodman WK, Christensen R. High doses of sertraline for treatment-resistant obsessive-compulsive disorder. Am J Psychiatry. 1996 Sep; 153(9):1232-3. PMID: 8780435.
      Citations: 1     Fields:    Translation:Humans
    307. Chappell P, Leckman J, Goodman W, Bissette G, Pauls D, Anderson G, Riddle M, Scahill L, McDougle C, Cohen D. Elevated cerebrospinal fluid corticotropin-releasing factor in Tourette's syndrome: comparison to obsessive compulsive disorder and normal controls. Biol Psychiatry. 1996 May 01; 39(9):776-83. PMID: 8731518.
      Citations: 23     Fields:    Translation:Humans
    308. Goodman WK, Kozak MJ, Liebowitz M, White KL. Treatment of obsessive-compulsive disorder with fluvoxamine: a multicentre, double-blind, placebo-controlled trial. Int Clin Psychopharmacol. 1996 Mar; 11(1):21-9. PMID: 8732310.
      Citations: 17     Fields:    Translation:HumansCTClinical Trials
    309. Morris MR, Blashfield RK, Rankupalli B, Bradley MM, Goodman WK. Subclinical obsessive-compulsive disorder in college students. Depress Anxiety. 1996-1997; 4(5):233-6. PMID: 9167789.
      Citations:    Fields:    Translation:Humans
    310. McDougle CJ, Barr LC, Goodman WK, Pelton GH, Aronson SC, Anand A, Price LH. Lack of efficacy of clozapine monotherapy in refractory obsessive-compulsive disorder. Am J Psychiatry. 1995 Dec; 152(12):1812-4. PMID: 8526253.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    311. Goodman WK, McDougle CJ, Price LH, Barr LC, Hills OF, Caplik JF, Charney DS, Heninger GR. m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: absence of symptom exacerbation. Biol Psychiatry. 1995 Aug 01; 38(3):138-49. PMID: 7578657.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    312. Goddard AW, Charney DS, Germine M, Woods SW, Heninger GR, Krystal JH, Goodman WK, Price LH. Effects of tryptophan depletion on responses to yohimbine in healthy human subjects. Biol Psychiatry. 1995 Jul 15; 38(2):74-85. PMID: 7578653.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    313. McDougle CJ, Kresch LE, Goodman WK, Naylor ST, Volkmar FR, Cohen DJ, Price LH. A case-controlled study of repetitive thoughts and behavior in adults with autistic disorder and obsessive-compulsive disorder. Am J Psychiatry. 1995 May; 152(5):772-7. PMID: 7726318.
      Citations: 50     Fields:    Translation:Humans
    314. Calvocoressi L, Lewis B, Harris M, Trufan SJ, Goodman WK, McDougle CJ, Price LH. Family accommodation in obsessive-compulsive disorder. Am J Psychiatry. 1995 Mar; 152(3):441-3. PMID: 7864273.
      Citations: 95     Fields:    Translation:Humans
    315. Leckman JF, Goodman WK, Anderson GM, Riddle MA, Chappell PB, McSwiggan-Hardin MT, McDougle CJ, Scahill LD, Ort SI, Pauls DL, et al. Cerebrospinal fluid biogenic amines in obsessive compulsive disorder, Tourette's syndrome, and healthy controls. Neuropsychopharmacology. 1995 Feb; 12(1):73-86. PMID: 7766289.
      Citations: 32     Fields:    Translation:HumansCTClinical Trials
    316. Pauls DL, Alsobrook JP, Goodman W, Rasmussen S, Leckman JF. A family study of obsessive-compulsive disorder. Am J Psychiatry. 1995 Jan; 152(1):76-84. PMID: 7802125.
      Citations: 148     Fields:    Translation:Humans
    317. Foa EB, Kozak MJ, Goodman WK, Hollander E, Jenike MA, Rasmussen SA. DSM-IV field trial: obsessive-compulsive disorder. Am J Psychiatry. 1995 Jan; 152(1):90-6. PMID: 7802127.
      Citations: 74     Fields:    Translation:HumansCTClinical Trials
    318. Goddard AW, Sholomskas DE, Walton KE, Augeri FM, Charney DS, Heninger GR, Goodman WK, Price LH. Effects of tryptophan depletion in panic disorder. Biol Psychiatry. 1994 Dec 01; 36(11):775-7. PMID: 7858076.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    319. Leckman JF, Goodman WK, North WG, Chappell PB, Price LH, Pauls DL, Anderson GM, Riddle MA, McSwiggan-Hardin M, McDougle CJ, et al. Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with Tourette's syndrome and healthy controls. Arch Gen Psychiatry. 1994 Oct; 51(10):782-92. PMID: 7524462.
      Citations: 36     Fields:    Translation:Humans
    320. Tollefson GD, Rampey AH, Potvin JH, Jenike MA, Rush AJ, kominguez RA, Koran LM, Shear MK, Goodman W, Genduso LA. A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry. 1994 Jul; 51(7):559-67. PMID: 8031229.
      Citations: 29     Fields:    Translation:HumansCTClinical Trials
    321. Leckman JF, Walker DE, Goodman WK, Pauls DL, Cohen DJ. "Just right" perceptions associated with compulsive behavior in Tourette's syndrome. Am J Psychiatry. 1994 May; 151(5):675-80. PMID: 8166308.
      Citations: 32     Fields:    Translation:Humans
    322. McDougle CJ, Goodman WK, Leckman JF, Lee NC, Heninger GR, Price LH. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. Arch Gen Psychiatry. 1994 Apr; 51(4):302-8. PMID: 8161290.
      Citations: 76     Fields:    Translation:HumansCTClinical Trials
    323. Barr LC, Goodman WK, McDougle CJ, Delgado PL, Heninger GR, Charney DS, Price LH. Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors. Arch Gen Psychiatry. 1994 Apr; 51(4):309-17. PMID: 8161291.
      Citations: 25     Fields:    Translation:HumansCTClinical Trials
    324. Holzer JC, Goodman WK, McDougle CJ, Baer L, Boyarsky BK, Leckman JF, Price LH. Obsessive-compulsive disorder with and without a chronic tic disorder. A comparison of symptoms in 70 patients. Br J Psychiatry. 1994 Apr; 164(4):469-73. PMID: 8038934.
      Citations: 19     Fields:    Translation:Humans
    325. McDougle CJ, Goodman WK, Price LH. Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorder. J Clin Psychiatry. 1994 Mar; 55 Suppl:24-31. PMID: 7521326.
      Citations: 14     Fields:    Translation:Humans
    326. Barr LC, Goodman WK, Price LH. Physical symptoms associated with paroxetine discontinuation. Am J Psychiatry. 1994 Feb; 151(2):289. PMID: 8296907.
      Citations: 6     Fields:    Translation:Humans
    327. Leckman JF, Goodman WK, North WG, Chappell PB, Price LH, Pauls DL, Anderson GM, Riddle MA, McDougle CJ, Barr LC, et al. The role of central oxytocin in obsessive compulsive disorder and related normal behavior. Psychoneuroendocrinology. 1994; 19(8):723-49. PMID: 7991761.
      Citations: 24     Fields:    Translation:HumansAnimals
    328. Leckman JF, Grice DE, Barr LC, de Vries AL, Martin C, Cohen DJ, McDougle CJ, Goodman WK, Rasmussen SA. Tic-related vs. non-tic-related obsessive compulsive disorder. Anxiety. 1994-1995; 1(5):208-15. PMID: 9160576.
      Citations: 46     Fields:    Translation:Humans
    329. McDougle CJ, Goodman WK, Leckman JF, Price LH. The psychopharmacology of obsessive compulsive disorder. Implications for treatment and pathogenesis. Psychiatr Clin North Am. 1993 Dec; 16(4):749-66. PMID: 8309811.
      Citations: 9     Fields:    Translation:Humans
    330. Calvocoressi L, McDougle CI, Wasylink S, Goodman WK, Trufan SJ, Price LH. Inpatient treatment of patients with severe obsessive-compulsive disorder. Hosp Community Psychiatry. 1993 Dec; 44(12):1150-4. PMID: 8132187.
      Citations: 3     Fields:    Translation:Humans
    331. Barr LC, Goodman WK, Price LH. The serotonin hypothesis of obsessive compulsive disorder. Int Clin Psychopharmacol. 1993 Nov; 8 Suppl 2:79-82. PMID: 8201248.
      Citations: 12     Fields:    Translation:HumansAnimals
    332. McDougle CJ, Goodman WK, Leckman JF, Barr LC, Heninger GR, Price LH. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder. J Clin Psychopharmacol. 1993 Oct; 13(5):354-8. PMID: 8227493.
      Citations: 17     Fields:    Translation:HumansCTClinical Trials
    333. Goddard AW, Woods SW, Sholomskas DE, Goodman WK, Charney DS, Heninger GR. Effects of the serotonin reuptake inhibitor fluvoxamine on yohimbine-induced anxiety in panic disorder. Psychiatry Res. 1993 Aug; 48(2):119-33. PMID: 8416022.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    334. Goodman WK, McDougle CJ, Barr LC, Aronson SC, Price LH. Biological approaches to treatment-resistant obsessive compulsive disorder. J Clin Psychiatry. 1993 Jun; 54 Suppl:16-26. PMID: 8331098.
      Citations: 8     Fields:    Translation:Humans
    335. McDougle CJ, Goodman WK, Price LH. The pharmacotherapy of obsessive-compulsive disorder. Pharmacopsychiatry. 1993 May; 26 Suppl 1:24-9. PMID: 8378419.
      Citations: 6     Fields:    Translation:Humans
    336. McDougle CJ, Naylor ST, Goodman WK, Volkmar FR, Cohen DJ, Price LH. Acute tryptophan depletion in autistic disorder: a controlled case study. Biol Psychiatry. 1993 Apr 01; 33(7):547-50. PMID: 8513041.
      Citations: 15     Fields:    Translation:HumansCTClinical Trials
    337. McDougle CJ, Goodman WK, Leckman JF, Holzer JC, Barr LC, McCance-Katz E, Heninger GR, Price LH. Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder. Am J Psychiatry. 1993 Apr; 150(4):647-9. PMID: 8465885.
      Citations: 14     Fields:    Translation:HumansCTClinical Trials
    338. Rotter M, Goodman W. The relationship between insight and control in obsessive-compulsive disorder: implications for the insanity defense. Bull Am Acad Psychiatry Law. 1993; 21(2):245-52. PMID: 8364240.
      Citations: 2     Fields:    Translation:Humans
    339. Goodman WK, Price LH. Assessment of severity and change in obsessive compulsive disorder. Psychiatr Clin North Am. 1992 Dec; 15(4):861-9. PMID: 1461801.
      Citations: 19     Fields:    Translation:Humans
    340. Barr LC, Goodman WK, Price LH. Acute exacerbation of body dysmorphic disorder during tryptophan depletion. Am J Psychiatry. 1992 Oct; 149(10):1406-7. PMID: 1388335.
      Citations: 7     Fields:    Translation:Humans
    341. McDougle CJ, Price LH, Volkmar FR, Goodman WK, Ward-O'Brien D, Nielsen J, Bregman J, Cohen DJ. Clomipramine in autism: preliminary evidence of efficacy. J Am Acad Child Adolesc Psychiatry. 1992 Jul; 31(4):746-50. PMID: 1644740.
      Citations: 13     Fields:    Translation:Humans
    342. Goodman WK, McDougle CJ, Price LH. The role of serotonin and dopamine in the pathophysiology of obsessive compulsive disorder. Int Clin Psychopharmacol. 1992 Jun; 7 Suppl 1:35-8. PMID: 1517555.
      Citations: 8     Fields:    Translation:Humans
    343. Barr LC, Goodman WK, Price LH, McDougle CJ, Charney DS. The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies. J Clin Psychiatry. 1992 Apr; 53 Suppl:17-28. PMID: 1532961.
      Citations: 27     Fields:    Translation:Humans
    344. Goodman WK, McDougle CJ, Price LH. Pharmacotherapy of obsessive compulsive disorder. J Clin Psychiatry. 1992 Apr; 53 Suppl:29-37. PMID: 1532962.
      Citations: 7     Fields:    Translation:Humans
    345. King RA, Riddle MA, Goodman WK. Psychopharmacology of obsessive-compulsive disorder in Tourette syndrome. Adv Neurol. 1992; 58:283-91. PMID: 1414634.
      Citations:    Fields:    Translation:Humans
    346. Boyarsky BK, Perone LA, Lee NC, Goodman WK. Current treatment approaches to obsessive-compulsive disorder. Arch Psychiatr Nurs. 1991 Oct; 5(5):299-306. PMID: 1750780.
      Citations:    Fields:    Translation:Humans
    347. McDougle CJ, Price LH, Goodman WK, Charney DS, Heninger GR. A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy. J Clin Psychopharmacol. 1991 Jun; 11(3):175-84. PMID: 1820757.
      Citations: 15     Fields:    Translation:HumansCTClinical Trials
    348. Wexler BE, Goodman WK. Cerebral laterality, perception of emotion, and treatment response in obsessive-compulsive disorder. Biol Psychiatry. 1991 May 01; 29(9):900-8. PMID: 2049488.
      Citations: 5     Fields:    Translation:Humans
    349. McDougle CJ, Price LH, Goodman WK. Fluvoxamine treatment of coincident autistic disorder and obsessive-compulsive disorder: a case report. J Autism Dev Disord. 1990 Dec; 20(4):537-43. PMID: 2126264.
      Citations: 8     Fields:    Translation:Humans
    350. Delgado PL, Goodman WK, Price LH, Heninger GR, Charney DS. Fluvoxamine/pimozide treatment of concurrent Tourette's and obsessive-compulsive disorder. Br J Psychiatry. 1990 Nov; 157:762-5. PMID: 2126219.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    351. Goodman WK, McDougle CJ, Price LH, Riddle MA, Pauls DL, Leckman JF. Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder? J Clin Psychiatry. 1990 Aug; 51 Suppl:36-43; discussion 55-8. PMID: 2199433.
      Citations: 43     Fields:    Translation:Humans
    352. Leckman JF, Goodman WK, Riddle MA, Hardin MT, Anderson GM. Low CSF 5HIAA and obsessions of violence: report of two cases. Psychiatry Res. 1990 Jul; 33(1):95-9. PMID: 1699245.
      Citations: 1     Fields:    Translation:Humans
    353. Goodman WK, Price LH, Delgado PL, Palumbo J, Krystal JH, Nagy LM, Rasmussen SA, Heninger GR, Charney DS. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine. Arch Gen Psychiatry. 1990 Jun; 47(6):577-85. PMID: 2112374.
      Citations: 40     Fields:    Translation:HumansCTClinical Trials
    354. McDougle CJ, Goodman WK, Price LH, Delgado PL, Krystal JH, Charney DS, Heninger GR. Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder. Am J Psychiatry. 1990 May; 147(5):652-4. PMID: 1970224.
      Citations: 23     Fields:    Translation:Humans
    355. Price LH, Charney DS, Delgado PL, Goodman WK, Krystal JH, Woods SW, Heninger GR. Clinical data on the role of serotonin in the mechanism(s) of action of antidepressant drugs. J Clin Psychiatry. 1990 Apr; 51 Suppl:44-50; discussion 51-2. PMID: 2182616.
      Citations: 5     Fields:    Translation:Humans
    356. DeVeaugh-Geiss J, Katz R, Landau P, Goodman W, Rasmussen S. Clinical predictors of treatment response in obsessive compulsive disorder: exploratory analyses from multicenter trials of clomipramine. Psychopharmacol Bull. 1990; 26(1):54-9. PMID: 2196627.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    357. Price LH, Charney DS, Delgado PL, Goodman WK, Krystal JH, Woods SW, Heninger GR. Clinical studies of 5-HT function using i.v. L-tryptophan. Prog Neuropsychopharmacol Biol Psychiatry. 1990; 14(4):459-72. PMID: 2236580.
      Citations: 6     Fields:    Translation:HumansAnimals
    358. Chouinard G, Goodman W, Greist J, Jenike M, Rasmussen S, White K, Hackett E, Gaffney M, Bick PA. Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder. Psychopharmacol Bull. 1990; 26(3):279-84. PMID: 2274626.
      Citations: 18     Fields:    Translation:HumansCTClinical Trials
    359. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry. 1989 Nov; 46(11):1006-11. PMID: 2684084.
      Citations: 1549     Fields:    Translation:Humans
    360. Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS. The Yale-Brown Obsessive Compulsive Scale. II. Validity. Arch Gen Psychiatry. 1989 Nov; 46(11):1012-6. PMID: 2510699.
      Citations: 577     Fields:    Translation:Humans
    361. McDougle CJ, Goodman WK, Delgado PL, Price LH. Pathophysiology of obsessive-compulsive disorder. Am J Psychiatry. 1989 Oct; 146(10):1350-1. PMID: 2782483.
      Citations: 2     Fields:    Translation:Humans
    362. Goodman WK, Price LH, Rasmussen SA, Delgado PL, Heninger GR, Charney DS. Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo. Arch Gen Psychiatry. 1989 Jan; 46(1):36-44. PMID: 2491940.
      Citations: 43     Fields:    Translation:HumansCTClinical Trials
    363. Goodman WK, Price LH, Rasmussen SA, Heninger GR, Charney DS. Fluvoxamine as an antiobsessional agent. Psychopharmacol Bull. 1989; 25(1):31-5. PMID: 2505302.
      Citations: 2     Fields:    Translation:Humans
    364. Heninger GR, Charney DS, Price LH, Delgado P, Woods S, Goodman W. Effects of serotonergic agonists on neuroendocrine responses of rhesus monkeys and patients with depression and anxiety disorders. Psychopharmacol Ser. 1989; 7:94-104. PMID: 2687871.
      Citations: 1     Fields:    Translation:HumansAnimals
    365. Charney DS, Goodman WK, Price LH, Woods SW, Rasmussen SA, Heninger GR. Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects. Arch Gen Psychiatry. 1988 Feb; 45(2):177-85. PMID: 3337615.
      Citations: 24     Fields:    Translation:Humans
    366. Woods SW, Charney DS, Goodman WK, Heninger GR. Carbon dioxide-induced anxiety. Behavioral, physiologic, and biochemical effects of carbon dioxide in patients with panic disorders and healthy subjects. Arch Gen Psychiatry. 1988 Jan; 45(1):43-52. PMID: 3122696.
      Citations: 19     Fields:    Translation:HumansCTClinical Trials
    367. Price LH, Goodman WK, Charney DS, Rasmussen SA, Heninger GR. Treatment of severe obsessive-compulsive disorder with fluvoxamine. Am J Psychiatry. 1987 Aug; 144(8):1059-61. PMID: 3111279.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    368. Charney DS, Woods SW, Goodman WK, Heninger GR. Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks. Am J Psychiatry. 1987 Aug; 144(8):1030-6. PMID: 3037926.
      Citations: 46     Fields:    Translation:Humans
    369. Charney DS, Woods SW, Goodman WK, Heninger GR. Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects. Psychopharmacology (Berl). 1987; 92(1):14-24. PMID: 3110824.
      Citations: 45     Fields:    Translation:Humans
    370. Rasmussen SA, Goodman WK, Woods SW, Heninger GR, Charney DS. Effects of yohimbine in obsessive compulsive disorder. Psychopharmacology (Berl). 1987; 93(3):308-13. PMID: 2829264.
      Citations: 4     Fields:    Translation:Humans
    371. Goodman WK, Charney DS, Price LH, Woods SW, Heninger GR. Ineffectiveness of clonidine in the treatment of the benzodiazepine withdrawal syndrome: report of three cases. Am J Psychiatry. 1986 Jul; 143(7):900-3. PMID: 2872826.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    372. Goodman WK, Charney DS. Therapeutic applications and mechanisms of action of monoamine oxidase inhibitor and heterocyclic antidepressant drugs. J Clin Psychiatry. 1985 Oct; 46(10 Pt 2):6-24. PMID: 3900056.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    GOODMAN's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (621)
    Explore
    _
    Co-Authors (75)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _